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Abstract 
Proper cell-cell and cell-extracellular matrix (ECM) interactions are vital for cell 
migration and patterning of the vertebrate embryo. Matrix metalloproteinases (MMPs) and 
their inhibitors, reversion-inducing cysteine-rich proteins with Kazal motifs (RECK) and 
tissue inhibitors of metalloproteinases (TIMPs), are all differentially expressed during 
embryogenesis to regulate such ECM remodeling events and cell interactions. While TIMPs 
are a family of 4 secreted proteins that share overlapping substrate specificities of MMPs, 
RECK is unique in that it is a membrane-anchored MMP inhibitor that is embryonic lethal in 
mice. I used Xenopus laevis as a model organism to investigate the role of RECK as a 
regulator of ECM turnover during development. The X. laevis RECK sequence was 
compared to a breadth of vertebrate and a few invertebrate RECK amino acid sequences. The 
X. laevis RECK amino acid sequence was found to be highly conserved with other RECK 
proteins. RECK knockdown in X. laevis embryos resulted in neural tube closure failure and 
axial defects, in part due to altered mRNA levels of MT1-MMP, MMP-2, and TIMP-2. Upon 
examination of RECK, MT1-MMP, and TIMP-2 protein localization in different tissues 
throughout early X. laevis development, I found that all 3 proteins showed highly similar 
localization patterns, particularly in the dorsal-ventral differentiation of the neural tube. To 
further investigate RECK regulation of MMP activity in vitro, I used X. laevis A6 cells to 
knockdown, overexpress, and shed RECK from the cell surface. I demonstrated that changes 
in RECK levels (overexpression and cell surface shedding) that may reduce the ability of the 
cell to remodel the ECM are compensated for by increases in MT1-MMP and MMP-2 levels 
and changes in ERK signaling. Altogether, these results support a role for RECK in the 
regulation of ECM remodeling and tissue patterning during X. laevis development. 
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Summary for Lay Audience 
All cells secrete or release materials around themselves, allowing tissues to form. In 
multicellular organisms such as ourselves, some of these materials form a network (the 
extracellular matrix or ECM) in which the cells anchor themselves to. In adults, the ECM 
provides stability and a safe environment in which our cells can carry out their functions - 
muscle cells contract, nerve cells communicate, and so on. But the situation is different in a 
developing embryo. As animals grow from a fertilized egg, cells need to move. In adults, 
when cells move, it is often associated with a disease state, such as cancer cells 
metastasizing. Thus, understanding how cell movement is regulated is essential to both 
embryogenesis and adults. For cells to move around, the ECM network that surrounds them 
often has to be broken down and then remade. The molecules involved in this breakdown are 
called matrix metalloproteinases (MMPs), and one of their roles is to cleave the ECM. Their 
activity has to be tightly regulated as excessive ECM degradation is detrimental. Therefore, 
there are 2 other molecules, tissue inhibitors of metalloproteinases (TIMPs) and reversion-
inducing cysteine-rich protein with Kazal motifs (RECK), whose roles are to control MMPs. 
RECK is a protein found on the surface of cells and stops cells from moving by preventing 
MMPs from cleaving components of the ECM. RECK has been identified as a crucial player 
during embryogenesis, though exactly why RECK is essential to development remains 
unclear. My research examined the role of RECK during frog development. I found that 
reducing RECK levels in frog embryos caused abnormal development, particularly in the 
formation of the spinal cord. These defects were in part due to improper ECM degradation. 
Additionally, I found that RECK is associated with MMPs even after cells migrate, at a time 
when embryonic cells are beginning to specialize, particularly into nerve cells. Thus, in 
addition to regulating MMPs when cells are migrating, RECK also plays a role after ECM 
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breakdown to signal to and help cells function. Overall, my study supports the role for RECK 
as an important regulator of cell movement during embryogenesis. 
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Chapter 1  
1 Global Introduction and Literature Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter have been published as a review article: “Willson, J.A. and 
Damjanovski, S. (2014). Vertebrate RECK in development and disease. Trends in Cell 
and Molecular Biology, 9: 95-105”. (Reprint permission in Appendix A). The text has 
been modified from the original manuscript to adhere to formatting guidelines for this 
thesis. J.A.W. wrote the manuscript and S.D. edited the manuscript.    
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1.1 The Extracellular Matrix 
The extracellular matrix (ECM) is the non-cellular network of interacting 
macromolecules that surrounds cells in metazoans. It is primarily composed of 
proteoglycans, which are large hydrophilic molecules, and large fibrous proteins, such as 
collagens and fibronectin, that provide structural support to cells. These fibrous proteins 
may contain important signaling domains, such as the epidermal growth factor (EGF) 
domain of laminin and heparin-II domain of fibronectin, which influence cell behaviour 
(Daley et al., 2008). There are 2 main types of ECM in animal tissues: basement 
membrane and interstitial matrix. The basement membrane is a thin layer of defined 
ECM that underlies epithelial cells, providing a barrier between epithelia and 
mesenchyme, whereas the interstitial matrix is a vast network of ECM surrounding 
sparsely packed cells that make up connective tissue, such as cartilage and bone (McKee 
et al., 2019). The amount and composition of ECM is specific to each type of tissue and 
is crucial for the overall integrity and function of that tissue. 
 The ECM not only provides a scaffolding network for cells, but it also sequesters 
a variety of signaling molecules including cytokines and growth factors, that once 
released, regulate cell growth, survival, migration, and differentiation (Daley et al., 
2008). Changes in cell-cell and cell-ECM contact and the release of these sequestered 
proteins occur through cleavage and remodeling of the ECM, and as such, these 
processes are crucial for proper development and maintenance of multicellular organisms 
(Daley et al., 2008). The integrity and breakdown of the ECM is regulated mainly 
through the combined action of a group of extracellular proteases called matrix 
metalloproteinases (MMPs).    
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1.2 Matrix Metalloproteinases 
There are 24 vertebrate MMPs, each with their own, but overlapping, ECM 
substrate specificities. MMPs are present in all metazoans and their expression is crucial 
in guiding many embryonic cell signaling and migration events (Visse and Nagase, 
2003). MMPs are classified into 2 categories based on their localization and structure: 
secreted MMPs, which are soluble in the ECM, and membrane type (MT)-MMPs, which 
are tethered to the cell membrane. The 3 common domains of MMPs are an N-terminal 
signal sequence that targets them for secretion, a pro-domain that inhibits catalytic 
activity, and a catalytic domain with endopeptidase activity (summarized in Fig. 1.1). All 
MMPs are synthesized as inactive zymogens and become activated with the removal of 
their pro-domain. MT-MMPs reach the cell surface in an active form, as they have their 
pro-domain cleaved intracellularly in the Golgi by furin-like proteases, whereas secreted 
MMPs are activated in the ECM by other active MMPs already present (Sternlicht and 
Werb, 2001). Once active, the common, but not only function of all MMPs, is to cleave 
and remodel the ECM through selective degradation of ECM proteins (Vu and Werb, 
2000).   
1.2.1 MT1-MMP 
A well-characterized member of the MMP family is MT1-MMP. Unlike secreted 
MMPs, which can diffuse freely though the ECM, MT-MMPs are anchored to the cell 
surface and their function is therefore restricted to the pericellular space (Seiki, 2002). Of 
the many MMP null mice, only MT1-MMP null mice die shortly after birth due to severe 
skeletal defects (Holmbeck et al., 1999). MT1-MMP can cleave major components of the 
ECM, including collagen types I, II, and III, but it can also cleave non-ECM proteins, 
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Figure 1.1 MMP domain structure.  
The various domains of human MMPs are shown. SP=signal peptide, Pro=pro-domain, 
Cat=catalytic domain, F=fibronectin II repeats, PEX=hemopexin domain, 
TM=transmembrane domain, C=cytoplasmic domain, GPI=Glycosylphosphatidylinositol 
anchor, Cys=cysteine array, Ig=immunoglobulin-like domain. The flexible hinge region 
is shown by the black zigzag line. (Modified from Radisky and Radisky, 2015). 
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such as clusters of differentiation 44 (CD44) and activate pro-MMP-2 (Gifford and Itoh, 
2019). These non-proteolytic functions may in fact help to explain its embryonic 
necessity.  
One of the confounding properties of MT1-MMP is its ability to cause an increase 
in cell migration even when it is in a proteolytically inactive form (Bonnans et al., 2008; 
Hara et al., 2011). These studies suggest that MT1-MMP may influence cell migration 
beyond a role that relies solely on ECM degradation. In fact, recent studies have shed 
light on a new mechanism of MT1-MMP involving extracellular signal-regulated (ERK) 
activation (Cepeda et al., 2016; Cepeda et al., 2017; Takino et al., 2010; Willson et al., 
2018). The mitogen-activated protein kinase (MAPK)/ERK pathway is a signaling 
cascade that is initiated by an extracellular mitogen, which subsequently leads to the 
activation of ERK and the transcription of various genes involved in growth, survival, 
differentiation, and development (Morrison, 2012). These multifunctional properties 
reveal the importance of MT1-MMP in both cell-ECM interactions as well as cellular 
behaviour.      
1.2.2 The Gelatinases 
The gelatinases, MMP-2 and MMP-9, have been identified as 2 potent secreted 
proteases due to their ability to cleave gelatin, but more importantly collagen type IV, a 
major component of basement membranes (Khasigov et al., 2003). Since cleavage of the 
basement membrane is an important step during cell migration, MMP-2 and MMP-9 have 
been implicated to play important roles during both development and cancer progression. 
Although the severity of defects that arise from knocking out only one MMP gene may be 
subdued due to functional redundancy between the different members of the MMP 
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family, defects have still been observed in single MMP knockout mice. For example, 
MMP-2 null mice display craniofacial defects (Mosig et al., 2007), and MMP-9 null mice 
exhibit defects in endochondral bone formation (Vu et al., 1998), both of which rely on 
extensive ECM degradation and cell migration.  
In adults, ECM remodeling is limited, and any disturbances in MMP levels can 
contribute to the onset and progression of diseases (Visse and Nagase, 2003). While the 
dysregulation of MMPs is associated with a number of disease states that involve cell 
migration, including atherosclerosis (Lin et al., 2014), fibrosis (Giannandrea and Parks, 
2014), and arthritis (Burrage et al., 2006), a major focus has been on their role in cancer, 
particularly the importance of MMP-2 and MMP-9, whose upregulation have been 
associated with tumour progression and metastasis (Bergers et al., 2000; Bernhard et al., 
1994; Jodele et al., 2005; Mook et al., 2004). Therefore, as it is crucial that MMP activity 
be tightly regulated, there are a number of different endogenous inhibitors that control 
MMP activity, including tissue inhibitors of metalloproteinases (TIMPs) (Visse and 
Nagase, 2003).   
1.3 Tissue Inhibitors of Metalloproteinases 
TIMPs, endogenous inhibitors of MMPs, are a small family of secreted proteins. 
All 4 TIMPs have been identified in mammals, but not all 4 are found in all vertebrates. 
For example, only TIMP-1, TIMP-2, and TIMP-3 have been identified in frog. 
Depending on the type, TIMPs are either expressed constitutively or in a tissue-specific 
manner, and each are regulated at the transcriptional level through cytokine and growth 
factor signaling (Murphy, 2011). For example, TIMP-2 is constitutively expressed, 
whereas TIMP-3 is expressed predominantly in the central nervous system (Nuttall et al., 
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2004). Overall, each TIMP has overlapping abilities to inhibit members of the MMP 
family. TIMPs contain structurally and functionally distinct N- and C-terminal domains. 
The N-terminal domain binds to MMPs with a 1:1 molar stoichiometry and inhibits MMP 
catalytic activity (Gomis-Ruth et al., 1997), whereas the C-terminal domain functions 
independently by binding to cell surface receptors and inducing cell signaling cascades 
(Visse and Nagase, 2003).  
One of the best described non-MMP-inhibitory functions of TIMPs involves 
TIMP-2. As previously mentioned in Section 1.2.1, an important function of MT1-MMP 
is its ability to activate pro-MMP-2 (Itoh et al., 2001). The mechanism involves binding 
of the C-terminal domain of TIMP-2 to the hemopexin-like domain of pro-MMP-2, while 
the N-terminal domain of that same TIMP-2 molecule binds the catalytic site of 
MT1-MMP and inhibits its proteolytic activity. This complex then allows an adjacent 
active MT1-MMP molecule to cleave the pro-domain of MMP-2, which releases it from 
the complex in an intermediate form. The intermediate form of MMP-2 then 
autocatalyzes into its active form (Fig. 1.2) (Itoh et al., 2001). This ability of MT1-MMP 
to activate MMP-2 and thus increase ECM remodeling therefore further potentiates cell 
migration. 
Due to their importance in mediating ECM turnover, the balance between MMPs 
and TIMPs is crucial for proper development to occur.  For example, overexpression of 
TIMP-1, TIMP-2 or TIMP-3 during early Xenopus laevis development all resulted in 
severe developmental defects (Nieuwesteeg et al., 2012; 2014). Until recently, TIMPs 
were thought to be the main MMP inhibitors, however, another protein has been 
discovered to play a role in mediating MMP activity. Reversion-inducing cysteine-rich 
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Figure 1.2 Pro-MMP-2 activation. 
The C-terminal domain of TIMP-2 binds to the hemopexin-like domain of pro-MMP-2, 
while the N-terminal domain of TIMP-2 binds the catalytic site of a MT1-MMP. An 
adjacent active MT1-MMP protein then cleaves the pro-domain of MMP-2, thus 
releasing MMP-2 in its intermediate form. The intermediate form of MMP-2 then 
undergoes autocatalytic cleavage to generate an active form of MMP-2. (Based on Itoh et 
al., 2001).  
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protein with Kazal motifs (RECK) encodes a membrane-anchored protein and regulates 
ECM remodeling by inhibiting MMP activity (Takahashi et al., 1998). 
1.4 RECK  
1.4.1 Protein Structure 
RECK was originally discovered by screening a human fibroblast cDNA library 
for genes that induced flat cell morphology (reversion-inducing clones) when expressed 
in transformed mouse fibroblasts (Takahashi et al., 1998). Mammalian RECK proteins 
are 971 amino acids in length and weigh approximately 110 kDa (Takahashi et al., 1998). 
Many vertebrate and invertebrate RECK sequences cloned to date are highly conserved at 
the amino acid level and share the domains characteristic of RECK (Willson and 
Damjanovski, 2014). RECK proteins contain hydrophobic regions flanking both ends of 
the protein. The N-terminal region encodes a signal peptide sequence and the C-terminal 
region encodes a glycosylphosphatidylinositol (GPI)-anchoring signal sequence (Fig. 1.3) 
(Takahashi et al., 1998). RECK was confirmed as a GPI-anchored protein by treatment 
with phospholipase C, an enzyme that selectively cleaves GPI-anchored proteins from the 
surface of cells (Takahashi et al., 1998). RECK proteins are also rich in cysteine residues 
(9%) and contain 5 repeats of a putative cysteine knot motif located near their N-terminus 
(Fig. 1.3) (Takahashi et al., 1998).  
As the name suggests, RECK proteins contain Kazal motifs, which are 
serine-protease inhibitor-like domains (Fig. 1.3) (Rimphanitchayakit and Tassanakajon, 
2010). There are 3 Kazal motif domains in RECK proteins. Evidence shows that these 
Kazal motifs play an important role in MMP inhibition (Chang et al., 2008). The middle 
portion of RECK proteins also contains 2 partial EGF-like repeats (Fig. 1.3) (Takahashi 
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Figure 1.3 Domain organization of a typical RECK protein based on the 971 amino 
acid human protein sequence.  
Mammalian RECK proteins contain a signal sequence at the N-terminus and a GPI 
anchor signal sequence at the C-terminus (which are not present in the mature protein). 
The N-terminal region of RECK contains 5 putative cysteine knot motifs. The C-terminal 
region contains 3 Kazal motifs (MMP inhibitory domains) and 2 epidermal growth 
factor-like repeats. (Adapted from Takahashi et al., 1998).  
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et al., 1998). EGF domains are common to membrane-bound and secreted proteins and 
have the potential to bind to EGF receptors and stimulate mitosis (Wouters et al., 2005). 
1.4.2 Tumour Suppression 
Since its discovery in transformed fibroblasts, RECK quickly became recognized 
as a tumour suppressor protein, and studies were carried out to determine if there was a 
correlation between RECK expression and tumour cell invasiveness. In normal adult 
tissues, RECK mRNA is relatively highly expressed, however, RECK expression is low 
and sometimes undetectable in many tumour-derived cell lines (Takahashi et al., 1998). 
Takahashi et al. (1998) was the first to determine the anti-invasive properties of RECK 
by generating stable RECK-expressing fibrosarcoma cells and showing that invasiveness 
significantly decreased in RECK-expressing cells versus control. Soon after, various 
human tumours were analyzed to determine the relationship between RECK expression 
and prognosis, including breast (Span et al., 2003), lung (Takenaka et al., 2005), 
pancreatic (Masui et al., 2003), colorectal (Takeuchi et al., 2004), and prostate (Ohl et al., 
2005) cancer. These studies concluded that high RECK expression in tumours correlated 
with better prognosis and survival rate.  
Given that loss of RECK is associated with tumour progression, Walsh et al. 
(2015) examined if loss of RECK is sufficient to transform normal cells. They knocked 
down RECK in normal human mammary epithelial cells and examined cell 
transformation using xenograft assays. RECK knockdown was not sufficient to induce 
transformation (Walsh et al., 2015). Therefore, although reconstitution of RECK in 
transformed cells reduces invasiveness, loss of RECK does not lead to malignant 
transformation.  
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1.4.3 MMP Inhibition 
RECK was originally identified as a tumour suppressor due to its ability to 
regulate MMP activity (Takahashi et al., 1998). Numerous in vitro studies have shown 
that RECK can negatively regulate MMP-2, MMP-9, and MT1-MMP activity (Fig. 1.4) 
(Chang et al., 2008; Matsuzaki et al., 2018; Oh et al., 2001; Simizu et al., 2005; 
Takahashi et al., 1998). The pioneering study was conducted by Takahashi et al. (1998) 
who saw a decrease in the amount of pro-MMP-9 in serum collected from fibrosarcoma 
cells transfected with RECK. This result only occurred when RECK was membrane-
bound. When RECK was solubilized, pro-MMP-9 levels in the serum did not change 
(Takahashi et al., 1998). Oh et al. (2001) expanded on these results and reported that 
levels of active MMP-2 also decreased in RECK-expressing fibrosarcoma cells. They also 
showed that RECK can directly interact with MT1-MMP and inhibit its proteolytic 
activity.  
Since RECK proteins contain Kazal motifs, which are protease-inhibitor domains, 
it is no surprise that evidence suggests these domains play a role in MMP inhibition. 
Chang et al. (2008) generated recombinant proteins containing all 3 Kazal motifs (K123) 
or only the last 2 Kazal motifs (K23). Using human lung cancer cells, they showed that 
K23 recombinant proteins reduced pro-MMP-9 and active MMP-2 and MMP-9 levels. 
Moreover, K23 recombinant proteins bound directly to MMP-9. Surprisingly, K123 did 
not show any MMP inhibition, however, they attributed this result to protein misfolding 
(Chang et al., 2008). Their results also showed that RECK does not need to be 
membrane-bound in order for inhibition of pro-MMP-9 to occur (Chang et al., 2008), 
which   is  contrary  to  earlier  studies   that  claimed   they  did   not  see  a  reduction  in  
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Figure 1.4 Role of RECK as an MMP inhibitor.  
RECK is a membrane-anchored protein and has been shown to directly inhibit 
MT1-MMP, MMP-2, and MMP-9 activity. RECK can also inhibit the secretion of 
pro-MMP-9, although the mechanism is unknown. RECK has also been shown to inhibit 
MMP-9 transcription by preventing Fra-1 and c-Jun from binding to the TRE-1 binding 
site on the MMP-9 promoter region, leading to less secreted pro-MMP-9. (Based on 
Chang et al., 2008; Oh et al., 2001; Takagi et al., 2009; Takahashi et al., 1998). 
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pro-MMP-9 levels using solubilized RECK proteins (Takahashi et al., 1998). 
An important factor in the progression of tumour growth and metastasis is the 
branching of new vascular networks from pre-existing ones, termed angiogenesis 
(Hoeben et al., 2004). With respect to tumour progression, not only does RECK decrease 
invasiveness, but RECK has also been shown to suppress tumour angiogenesis. When 
RECK-expressing tumour cells were inoculated into mice, RECK+-tumoured mice lived 
longer and displayed a reduction in angiogenic sprouting, as was seen by laminin staining 
versus the mice inoculated with control tumours (Oh et al., 2001).  
As a GPI-anchored protein, RECK does not contain an intracellular domain, 
however, many GPI-anchored proteins are involved in transducing cell-signaling 
cascades by binding to neighboring receptors (Mayor and Riezman, 2004). Takagi et al. 
(2009) were the first to discover that RECK decreases MMP-9 transcription. 
Overexpression of RECK in fibrosarcoma cells caused a decrease in MMP-9 mRNA, but 
not MMP-2 mRNA. Although they also saw a decrease in the amount of MMP-9 present 
in the serum from RECK-expressing fibrosarcoma cells, they attributed this result to the 
decrease in MMP-9 mRNA, not inhibition of pro-MMP-9 secretion. They discovered that 
RECK overexpression suppressed the binding of Fos-related antigen 1 (Fra-1) and c-Jun 
transcription factors to the 12-O-tetradecanoylphorbol-13-acetate-responsive element-1 
(TRE-1) binding site within the MMP-9 promoter region in fibrosarcoma cells. However, 
the mechanisms underlying this process are currently unknown. For example, there is no 
evidence to suggest that RECK translocates to the nucleus. Instead, RECK may act on the 
surface of cells by interacting with other cell surface receptors (Takagi et al., 2009). 
In fact, a study has suggested that RECK may not only bind to MT1-MMP to 
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inhibit its catalytic activity, but it may also modulate the endocytic pathway of 
MT1-MMP. A study performed by Miki et al. (2007) examined whether RECK 
influences the clearance of MT1-MMP and CD13, another membrane protease, from the 
cell surface. They found that when RECK was present, it complexed with MT1-MMP 
and CD13 and caused preferential endocytosis of these proteins using a novel endocytic 
pathway that was caveolae-independent. This study highlights the multifaceted properties 
of RECK as a cell surface protein.  
1.5 Regulation of RECK 
1.5.1 Oncogenic Signaling Represses RECK Expression 
The MAPK/ERK pathway plays a crucial role in cell proliferation and 
differentiation, however, aberrant activity of this pathway can lead to malignant 
transformation (Kohno and Pouyssegur, 2006). For example, activated RAS causes a 
decrease in ECM proteins and receptors and an increase in MMPs, such as MT1-MMP 
(Howard et al., 1978; Plantefaber and Hynes, 1989; Thant et al., 1997). RECK was 
discovered as a downstream target of oncogenic signaling, as reconstitution of RECK in 
ras-transformed fibroblasts induced reversion (Takahashi et al., 1998). As such, studies 
have been carried out to determine how RECK is regulated at the transcriptional level by 
the MAPK/ERK pathway. There is a specificity protein 1 (Sp1)-binding site within the 
RECK promoter region that has been identified as a repressor of RECK transcription 
(Sasahara et al., 1999). Activation of ERK causes phosphorylation of Sp1, which is then 
recruited to the Sp1 binding site along with histone deacetylase 1 (HDAC) and results in 
repression of RECK transcription (Chang et al., 2004).  
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1.5.2 TIMP-2 Induces RECK Expression 
TIMPs are multi-faceted proteins. Not only do TIMPs inhibit MMPs, but they can 
also bind to cell surface receptors and induce cell-signaling cascades (Li et al., 1999; Oh 
et al., 2004). Of importance is the upregulation of RECK expression by TIMP-2. TIMP-2 
was shown to bind to α3β1 integrins on the surface of human endothelial cells, causing 
inactivation of proto-oncogene tyrosine-protein kinase (Src) through changes in paxillin 
phosphorylation (Oh et al., 2004). Alteration of paxillin phosphorylation regulates the 
activation of the small GTPase Ras-related protein 1 (Rap1), which ultimately results in 
increased expression of RECK through unknown mechanisms (Oh et al., 2004).  
1.5.3 Glycosylation of RECK 
RECK has also been shown to be regulated at the post-translational level. RECK 
contains 5 putative glycosylation sites at the N-terminal portion of the protein (Takahashi 
et al., 1998). Glycosylation of 3 of the 5 potential asparagines of RECK are required to 
suppress tumour cell invasion (Simizu et al., 2005). Simizu et al. (2005) generated RECK 
mutants where they replaced asparagines with glutamines. RECK mutant constructs were 
transfected into fibrosarcoma cells to measure the amount of MMP-2 and MMP-9 levels 
in the media. Glycosylation of Asn297 was required to inhibit MMP-9 secretion and 
Asn352 was required to inhibit the activation of pro-MMP-2. They also correlated 
glycosylation of RECK with tumour cell invasion and found that glycosylated Asn86, 
Asn297, and Asn352 residues were required to suppress fibrosarcoma cell invasion (Simizu 
et al., 2005).  
1.6 RECK in Development 
During embryonic development the ECM undergoes extensive remodeling. As 
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such, MMPs are expressed, and studies have found that aberrant upregulation of MMPs 
has been associated with developmental defects and death (Page-McCaw et al., 2007). 
Therefore, to maintain an appropriate level of MMP activity, MMP inhibitors are also 
crucial for proper development to occur. Although TIMP-1 or TIMP-2 deficiency in 
mouse embryos has little effect on development (Caterina et al., 2000; Nothnick et al., 
1997), most likely due to functional redundancy between TIMPs, RECK is necessary for 
mouse development. Oh et al. (2001) were the first to report that RECK knockout in mice 
resulted in embryonic lethality. 
1.6.1 Angiogenesis 
When the RECK gene was knocked out in mice, about 2/3 of RECK-/- embryos 
died halfway through embryogenesis at embryonic day (ED) 10.5, and none survived past 
ED11.5 (Oh et al., 2001). RECK-/- embryos had overt phenotypes, which included 
abdominal hemorrhaging, disorganized vascularization, disrupted organogenesis, and 
smaller body sizes (Oh et al., 2001). Although vascular networks were present in RECK-/- 
embryos, histological examination of these tissues indicated abnormally large and 
deformed blood vessels, which indicated defects in angiogenesis rather than 
vasculogenesis (Oh et al., 2001).  
Due to its characterized role in MMP inhibition, RECK-/- mice were analyzed to 
determine if there was aberrant upregulation of MMPs in vivo. Oh et al. (2001) plated 
ED10.5 cells and collected the serum. MMP-2 activity was elevated in RECK-/- embryos, 
however, since pro-MMP-9 is not expressed until ED11, MMP-9 activity was not 
detected (Oh et al., 2001). Collagen IV and laminin were also disrupted in areas 
surrounding blood vessels and the neural tube in RECK-/- embryos (Oh et al., 2001). 
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These results suggest that loss of RECK caused aberrant upregulation of MMPs and 
disruption of the basal lamina. This is supported by the fact that RECK, MMP-2, and 
MT1-MMP expression patterns overlap in the areas surrounding the neural tube. 
Furthermore, a similar phenotype was seen in collagen 1-/- mice, which also died due to 
ruptured blood vessels (Löhler et al., 1984). A partial rescue of the RECK mutant 
phenotype was obtained by generating RECK-/-/MMP-2-/- double mutants. These embryos 
had larger body sizes and improved vascular integrity, however, they still died half a day 
later (ED11.5) (Oh et al., 2001). On the other hand, RECK-/-/MT1-MMP-/- mutants did not 
rescue the RECK mutant phenotype (Oh et al., 2001).  
Chandana et al. (2010) tried a conditional RECK knockout by silencing the RECK 
gene using tamoxifen-inducible treatment at ED11, however, mice still showed lethality. 
Conditional RECK-/- mutants had large and deformed blood vessels as well as large 
cavities in the brain vasculature at ED15.5 (Chandana et al., 2010). This phenotype was 
also apparent when Prendergast et al. (2012) knocked down RECK in zebrafish using 
Morpholinos (MO). RECK knockdown embryos had impaired vascular integrity and 
intracranial hemorrhaging 48 hours post-fertilization (Prendergast et al., 2012). This 
suggests that RECK function is conserved throughout development and essential 
particularly with respect to vascular development.  
Since RECK was implicated to play a role in angiogenesis during development, 
Chandana et al. (2010) decided to examine the importance of RECK in maternal vascular 
remodeling in mice. The uterus of a pregnant mouse is one of the most active sites of 
angiogenesis in adult mice (Abrahamsohn and Zorn, 1993; Cross et al., 1994; Dey et al., 
2004). MMP-2 and MMP-9 expression patterns are very dynamic during vascular 
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remodeling in the uterus and are required for proper ECM remodeling (Curry and Osteen, 
2003; Wang and Dey, 2006). However, it is unclear how some blood vessels are 
protected while others undergo extensive vascular sprouting. RECK was implicated to 
play a role in vascular remodeling in maternal tissues. RECK is expressed in cells 
associated with remodeling blood vessels in the mouse implantation chamber (Chandana 
et al., 2010). When they knocked down RECK expression within the implantation 
chamber using short hairpin RNA (shRNA), cavities and tissue slits were present instead 
of organized and compact blood vessels (Chandana et al., 2010). They also saw decreased 
collagen IV surrounding the deformed blood vessels (Chandana et al., 2010). This 
phenotype is very similar to the vascular defects seen in RECK-/- embryos and supports 
the role of RECK as a key regulator during angiogenic sprouting (Chandana et al., 2010). 
Mechanisms of RECK action during angiogenesis have been proposed by Chandana et al. 
(2010). The most likely scenario suggests that RECK helps mark and protect the blood 
vessels that are preserved during angiogenic sprouting by inhibiting surrounding MMPs. 
However, RECK-/- embryos cannot be rescued by MMP null mutations, although this may 
be due to functional redundancy between MMPs. Instead, RECK may affect intracellular 
signaling pathways by protecting ECM proteins and other cell surface receptors 
(Chandana et al., 2010). Angiogenesis occurs when vascular endothelial growth factor 
(VEGF) and Notch signaling regulate endothelial tip cell formation (Adams and Alitalo, 
2007; Carmeliet, 2005; Roca and Adams, 2007). Delta-like 4 (Dll4), a ligand of Notch 
signaling, has been reported to reduce tip cell formation and thus vascular sprouting 
(Phng and Gerhardt, 2009). Interestingly, the vascular defects seen in RECK-/- embryos 
are very similar to the phenotype that occurs in mouse embryos with attenuated Notch 
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signaling (Krebs et al., 2000; Xue et al., 1999). RECK has been shown to activate Notch 
signaling during cortical neurogenesis by protecting Dll4 from being shed from the 
membrane (Muraguchi et al., 2007). Therefore, RECK deficiency may suppress Notch 
signaling during embryonic and maternal angiogenesis and cause excessive sprouting 
(Fig. 1.5). However, this mechanism of action does not solely explain the large cavities 
formed in RECK-deficient tissues. The biggest unanswered question that remains is why 
RECK is necessary for embryonic angiogenesis but suppresses tumour angiogenesis. 
Although it was recently discovered that RECK suppresses angiogenesis by 
downregulating signal transducer and activator of transcription 3 (STAT3) (Walsh et al., 
2015), no link has been made to whether or not this process occurs during developmental 
angiogenesis.  
1.6.2 Neurogenesis 
Notch signaling is a highly conserved pathway that is crucial during development to 
ensure cell fate specification, stem cell maintenance, and tissue patterning (Roca and 
Adams, 2007). In the mammalian central nervous system, Notch ligands, Dll and Jagged, 
are expressed on the surface of neural cells and bind to Notch present on the surface of 
neighboring neural precursor cells (Roca and Adams, 2007). Once activated, Notch 
signaling maintains neural precursor cells in an undifferentiated state (Roca and Adams, 
2007). Notch signaling is regulated by a disintegrin and metalloproteinase-10 
(ADAM-10) (Yang et al., 2006). ADAM-10 proteases are expressed throughout 
development in various neural cells in the mammalian central nervous system and inhibit 
Notch signaling by cleaving Notch ligands from the surface of neural cells to allow 
differentiation (Kärkkäinen et al., 2000; LaVoie and Selkoe, 2003; Mishra-Gorur et al., 
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Figure 1.5 Role of RECK in vascular sprouting.  
During vascular sprouting in tip cells, VEGF and Notch signaling modulate the selective 
formation of tip cells. VEGF signaling in tip cells leads to high levels of Dll4. Dll4 binds 
to Notch on neighboring stalk cells, which induces Notch signaling and attenuates 
VEGFR signaling. RECK has been proposed to regulate vascular sprouting by 
maintaining Notch signaling, however the mechanism is currently unknown. (Based on 
Muraguchi et al., 2007).   
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2002).  
RECK-/- mice embryos not only had vascular defects, but they also had premature 
differentiation of neural precursor cells (Muraguchi et al., 2007). This phenotype was a 
result of impaired Notch signaling in the central nervous system (Muraguchi et al., 2007). 
They demonstrated that RECK regulated Notch signaling by directly inhibiting 
ADAM-10 in neural precursor cells. They confirmed this by showing a direct interaction 
between RECK and ADAM-10 by co-immunoprecipitation as well as by 
co-electroporating shRNA targeting ADAM-10 and RECK in the central nervous system 
of ED12.5 wildtype embryos and rescuing the phenotype induced by RECK depletion 
(Muraguchi et al., 2007).  
A more recent study expanded on these results and reported that RECK was 
regulated within this pathway by glycerophosphodiester phosphodiesterase 2 (GDE2) 
(Park et al., 2013). GDE2 is a 6-transmembrane protein that is crucial for the 
differentiation of spinal motor neurons by inhibiting Notch signaling (Rao and 
Sockanathan, 2005; Sabharwal et al., 2011; Yan et al., 2009). Interestingly, GDE2 and 
RECK mRNA expression colocalize in differentiating motor neurons during neurogenesis 
in chicks (Park et al., 2013). Using chick spinal cord extracts, they determined that GDE2 
cleaves RECK within the GPI-anchor. The release of RECK prevents inhibition of 
ADAM-10, which then sheds Dll from the surface and attenuates Notch signaling 
(Fig. 1.6) (Park et al., 2013).  
1.6.3 Neural Crest Cell Migration 
Neural crest cells are a transient population of migratory cells that differentiate 
into a variety of cell types within the vertebrate embryo, including melanocytes, smooth 
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Figure 1.6 Role of RECK in neurogenesis. 
RECK maintains Notch signaling in neural progenitor cells by inhibiting the proteolytic 
activity of ADAM-10 on the surface of neural cells. ADAM-10 sheds Notch ligands from 
the surface, preventing the intracellular domain (ICD) of Notch to translocate to the 
nucleus and turn on target genes that maintain neural progenitor cells. The presence of 
RECK prevents shedding of Notch ligands and maintains Notch signaling. In addition, 
GDE2 regulates RECK by cleaving its GPI-anchor. This prevents inhibition of 
ADAM-10 and thus attenuates Notch signaling. (Based on Muraguchi et al., 2007; Park 
et al., 2013; Yang et al., 2006).  
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muscle, sensory ganglia, and craniofacial cartilage and bone (Le Douarin and Kalcheim, 
1999). RECK knockdown in zebrafish embryos was also reported to have defects in 
neural crest migration (Prendergast et al., 2012). Prendergast et al. (2012) began their 
study by screening zebrafish mutants that were unable to form the dorsal root ganglia 
(DRG) by looking at neurogenin expression and found that this phenotype was a result of 
a mutation in the RECK gene. In the absence of RECK, neural crest cells exhibited 
aberrant migratory behaviour and were unable to migrate to the appropriate position for 
differentiation into DRG.  They confirmed this phenotype by also knocking down RECK 
expression using MOs (Prendergast et al., 2012). RECK mutants displayed increased 
MMP activity, as shown by taking protein extracts from embryos and incubating them 
with dye-quenched (DQ) gelatin, a substrate that allows for quantification of MMP 
activity (Prendergast et al., 2012).  However, this phenotype could not be rescued by the 
treatment of MMP inhibitors (Prendergast et al., 2012). This study was also the first to 
determine that RECK function is cell autonomous. Cells taken from wildtype embryos 
and transplanted into RECK knockdown embryos were able to form DRG, but they 
couldn’t induce the host cells (RECK knockdown cells) to form DRG (Prendergast et al., 
2012). 
1.6.4 Limb Patterning 
When the RECK gene was knocked out in mice, embryos did not survive past 
ED11 (Oh et al., 2001). Therefore, although studies have focused on the role of RECK 
early on during development, little is understood regarding developmental processes 
occurring later in embryogenesis. Therefore, Yamamoto et al. (2012) generated 
low-RECK mutants, which have reduced RECK expression, to examine later stages of 
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development. The most obvious phenotype displayed in these mutants was limb 
abnormalities. Further histological examination showed poor chondrocyte condensation 
in forelimb buds (Yamamoto et al., 2012). To determine potential morphogenetic 
signaling molecules affected by low RECK expression in mice such as Wnt7a signaling 
and sonic hedgehog (Shh) signaling, in situ hybridization was performed. These signaling 
pathways were all attenuated in low-RECK mutants (Yamamoto et al., 2012). 
Interestingly, Wnt7a-/- embryos displayed very similar limb abnormality phenotypes, 
whereas deficiencies in the other signaling pathways (such as Shh or bone morphogenetic 
protein (BMP)) yielded distinctly different phenotypes (Adamska et al., 2004; Chiang et 
al., 1996; Selever et al., 2004). Indeed, Wnt7a expression was greatly reduced in 
low-RECK mutant forelimb buds. They came to the conclusion that RECK is required for 
Wnt7a signaling in the forelimb bud (Yamamoto et al., 2012).  
1.7 The X. laevis System 
The African clawed frog, X. laevis, has been widely used in the developmental biology 
field since the 1950s (Schmitt et al., 2014). The X. laevis system provides a number of 
advantages as a model organism, including the ease of in vitro fertilization and rearing as 
well as their resilience to experimental manipulation. Moreover, development occurs 
rapidly, and each stage has been well-characterized (Nieuwkoop and Faber, 1956). 
X. laevis embryos are large (approximately 1 mm in diameter) and therefore 
developmental stages are easily recognizable (Fig. 1.7). Development begins at 
fertilization (stage 1), followed by the blastula stage (stage 9), at which time zygotic 
transcription is turned on. Within the first 24 hours post fertilization, gastrulation occurs 
(stage  10-12),  in   which   the  3  germ   layers  are  formed   (ectoderm,  mesoderm,  and  
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Figure 1.7 Schematic representation of X. laevis developmental stages. 
(a) Development begins with a fertilized single cell egg. Stage 9 (blastula stage) marks 
the onset of zygotic transcription. Gastrulation occurs between stages 10 and 12 to form 
the 3 germ layers (ectoderm, mesoderm, and ectoderm) and the embryonic axes. 
Neurulation occurs between stages 14 and 20 to form the neural tube. Organogenesis and 
differentiation are predominant in the tailbud stages (stages 21-28) and beyond. By stage 
37 the embryo has hatched, and by stage 41 embryos have developed into feeding 
tadpoles. (b) Schematic representation of an early tailbud embryo to denote the 
embryonic axes. Dorsal refers to back and ventral refers to front (belly). Anterior refers to 
head and posterior refers to tail. (Adapted from Nieuwkoop and Faber, 1956).       
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endoderm) as well as the embryonic axes, followed by neurulation, which occurs between 
stages 14 and 20 to form the neural tube (neural crest cell migration begins during these 
stages as well). Organogenesis and differentiation begin at the tailbud stages, and by 3 
days post fertilization (dpf), a functional free-swimming tadpole has developed (Fig. 1.7). 
Thus, X. laevis has been a fundamental tool in studying cell cycle, cell metabolism, cell 
behaviour, and cell migration during development (Hardwick and Philpott, 2015). 
For a long time, investigators have taken advantage of the parallels that exist 
between embryonic development and cancer metastasis. Many signaling pathways that 
are crucial for normal development, such as BMP, Shh, and Notch pathways, become 
unregulated during cancer metastasis (Bailey et al., 2007). ECM remodeling is yet 
another example of an event that is highly dynamic during both development and cancer 
metastasis. Therefore, using X. laevis as a model organism to study ECM remodeling 
during development can assist in understanding why this process becomes uncontrolled 
during tumour progression. 
In vitro cell culture work can also be conducted using A6 cells, a well-established 
cell line derived from X. laevis kidney tissue. These cells behave like typical polarized 
epithelial cells and can be instrumental in studying cell signaling pathways and cell 
behaviour in vitro (Mimori-Kiyosue et al., 2007), pathways which can be difficult to 
discern in a multicellular embryo.       
1.8 Research Project 
1.8.1 Summary  
ECM remodeling is a highly dynamic process that is important for the 
development and maintenance of multicellular organisms. ECM degradation occurs 
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primarily through MMPs, and their activity is modulated by their endogenous inhibitors, 
TIMPs and RECK. Numerous studies have shown that perturbing the delicate balance 
that exists between MMPs and their inhibitors can lead to devastating consequences to 
the integrity and function of tissues. For example, uncontrolled ECM remodeling can 
contribute to the onset and progression of cancer metastasis. For these reasons, it is 
essential to understand the functions and interplay of these proteins and how they control 
ECM remodeling to ensure proper development and tissue homeostasis.  
The importance of RECK during development is becoming more evident, as 
studies have already identified a role for RECK during angiogenesis, neural crest cell 
migration, and limb patterning. Not only does RECK inhibit MMP function at many 
levels, there is also emerging evidence suggesting that RECK may play a more important 
role in regulating intracellular signaling. However, most research characterizing RECK 
function has been done in vitro in tumour-derived cell lines. My research focused on the 
functional characterization of RECK during X. laevis development, a well-established 
developmental model. By disrupting endogenous RECK levels, I attempted to elucidate 
the molecular mechanisms that are critical for balancing the proteolytic activity of MMPs 
with the role of RECK required for proper ECM remodeling and tissue patterning during 
development.  
1.8.2 Hypotheses 
1) Previous studies have revealed similar biological functions of RECK in 
vertebrates, therefore, I hypothesize that all domains of vertebrate RECK peptide 
sequences will share high evolutionary conservation. 
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2) Since RECK transcripts are localized to dorsal axial structures in X. laevis 
embryos, I hypothesize that alteration of RECK levels will cause axial and neural 
tube defects in X. laevis embryos resulting from excessive ECM remodeling.  
3) Previous studies have demonstrated that RECK is an inhibitor of MT1-MMP, 
therefore, I hypothesize that X. laevis RECK will colocalize with MT1-MMP in 
dorsal axial structures, including the neural tube and head region. 
4) Given that RECK has an established role as an MMP inhibitor, I hypothesize that 
knockdown/shedding of RECK in X. laevis A6 cells will result in increased 
MT1-MMP and MMP-2 levels, whereas overexpression of RECK will result in 
reduced MT1-MMP and MMP-2 levels.  
1.8.3 Objectives 
The overarching goal of this research was to characterize the role of X. laevis 
RECK during development. I previously cloned the mature X. laevis RECK sequence, 
which lacked the N-terminal signal sequence and C-terminal GPI-anchor signal sequence, 
as part of my Master’s thesis, and performed a preliminary sequence comparison analysis 
of RECK. However, that study was limited by the number of available annotated 
sequences at the time. For this Doctoral study, I finished cloning the full-length X. laevis 
RECK gene and performed a detailed sequence comparison of RECK with more diverse 
species to determine evolutionary conservation. This research had the following 
objectives:  
1) To perform a comparison of amino acid sequence identity of X. laevis RECK to 
other sequences to determine evolutionary conservation of domains (Chapter 2). 
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2) To knock down RECK in X. laevis embryos using a MO approach. Following 
RECK knockdown, to examine embryos for any subsequent morphological 
changes and developmental defects and correlate these defects with alterations in 
mRNA levels of developmental marker genes as well as ECM-remodeling genes 
(Chapter 2). 
3) To perform immunohistochemistry (IHC) on transverse sections of embryos to 
determine the localization patterns of RECK, MT1-MMP, and TIMP-2 during 
X. laevis neurulation and organogenesis (Chapter 3).  
4) To disrupt endogenous levels of RECK in X. laevis A6 cells using a combination 
of overexpression, knockdown, and phosphatidylinositol-specific phospholipase C 
(PI-PLC) treatment experiments and examine the effects on MT1-MMP, MMP-2 
and phosphorylated ERK (pERK) levels (Chapter 4).    
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Chapter 2  
2 Analysis of Xenopus laevis RECK and Its 
Relationship to Other Vertebrate RECK Sequences 
 
 
 
 
 
 
 
 
Data in this chapter have previously been published as: “Willson, J.A., Nieuwesteeg, 
M.A., Cepeda, M., and Damjanovski, S (2015). Analysis of Xenopus laevis RECK and its 
relationship to other vertebrate RECK sequences. Journal of Scientific Research and 
Reports, 6(7): 504-513.” Copyright on any open access article in a journal published by 
SCIENCEDOMAIN International is retained by me, the author, as per The Creative 
Commons Attribution License 4.0. The text has been modified from the original 
manuscript to adhere to formatting guidelines for this thesis. Figures 3 and 4 published in 
that article (RT-PCR and in situ analysis of RECK) are not novel to this thesis as they 
were included in my Master’s thesis, and thus have been excluded. The remaining 
published figures 1, 2, and 5 are novel to this PhD thesis. The figures regarding RECK 
MO knockdown in embryos are unpublished. Experiments were designed and carried out 
by J.A.W., M.A.N. assisted with embryo rearing, M.C. edited the manuscript, and S.D. 
provided funding, resources, and intellectual contributions.  
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2.1 Introduction 
During development the ECM undergoes extensive remodeling to allow needed 
large-scale cell movements to occur. Degradation of the ECM occurs through a large 
family of extracellular proteases called MMPs. Aberrant regulation of MMPs is 
associated with developmental defects, and therefore, a delicate balance between the 
levels of MMPs and their endogenous inhibitors is crucial for proper development. 
RECK has recently been discovered to play a role in regulating MMP activity (Takahashi 
et al., 1998).  
The RECK gene encodes a GPI-anchored protein with 3 serine-protease 
inhibitor-like domains (Kazal motifs) and 5 repeats of a putative cysteine knot motif. The 
N-terminus contains a signal peptide sequence and the C-terminus contains a 
GPI-anchoring signal sequence (Fig. 1.3) (Takahashi et al., 1998). All mammalian RECK 
genes that have been sequenced to date are highly conserved at the amino acid level and 
share the domains mentioned above. Mammalian RECK proteins are 971 amino acids in 
length and mass of approximately 110 kDa (Takahashi et al., 1998). RECK has also been 
sequenced from a variety of non-mammalian vertebrate and invertebrate species and has 
been found to be evolutionarily conserved, however, X. laevis RECK has yet to be 
characterized. Indeed, while numerous putative RECK genes can be predicted as many 
organism genomes are being sequenced, proportionally reptile and amphibian (herptile) 
RECK sequences are incomplete, of poor quality, or lacking in various phylogenic 
databases. 
RECK was first described as a tumour suppressor protein due to its anti-invasive 
properties. Numerous in vitro studies showed that RECK can inhibit the proteolytic 
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activity of 3 types of MMPs: MMP-2, MMP-9, and MT1-MMP (Oh et al., 2001; Takagi 
et al., 2009; Takahashi et al., 1998). Since RECK functions by inhibiting MMPs, its 
presence during development would suggest that it plays important embryonic roles as 
well. Vertebrate RECK importance was demonstrated in knockout and knockdown 
studies in mice and zebrafish, respectively. Oh et al. (2001) revealed that RECK-deficient 
mice died halfway through embryogenesis with halted vascular development. In addition, 
RECK knockdown in zebrafish resulted in impaired vascular integrity and lack of DRG 
formation (Prendergast et al., 2012). RECK has also been shown to be important during 
mouse secondary palate development (de Oliveira Demarchi et al., 2010) and mouse 
forelimb development (Yamamoto et al., 2012). More recently RECK has also been 
shown to modulate cell-migratory signaling pathways, independent of its MMP inhibitory 
role (Chang et al., 2008; Walsh et al., 2015). As the developmental processes of neural 
development and vascular branching both involve RECK and tightly controlled cell 
migration and ECM remodeling events in mice and zebrafish, this implicates the 
importance of RECK as a key embryonic regulator in other vertebrates.  
While much in vitro analysis of RECK function is currently being carried out, 
there is limited in vivo information regarding this protein, particularly in non-mammalian 
vertebrates. In this chapter, I cloned and analyzed the sequence of X. laevis RECK and 
examined its expression pattern during development. Expression analysis revealed that 
X. laevis RECK expression is consistent with its vascular and nervous system roles seen 
in mouse and zebrafish. I then used a MO approach to disrupt endogenous RECK levels 
in X. laevis embryos. RECK knockdown led to severe neural tube closure defects, axial 
defects, and reduced head structures. Additionally, polymerase chain reaction (PCR) 
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analysis showed that RECK knockdown resulted in differential changes in MMP and 
TIMP genes, suggesting that RECK is an important modulator of ECM remodeling 
during X. laevis embryogenesis. 
2.2 Materials and Methods 
2.2.1 Animal Care and Rearing 
Adult X. laevis were purchased from Xenopus 1, Inc (Dexter, MI). Animal rearing 
and fertilizations were carried out as previously described (Sive et al., 2000). Developing 
embryos were staged according to Nieuwkoop and Faber (1956) (Fig. 1.6). Animals were 
housed and treated in accordance with UWO and CCAC guidelines.  
2.2.2 Cloning X. laevis RECK 
Since the X. laevis RECK sequence was not available online at the beginning of 
this project, the Xenopus tropicalis database was used instead as the sequence of this 
closely related species is better annotated. Based on the putative X. tropicalis RECK 
sequence [XM_002938937.2], forward (5’-ATGTGTCGTGATGTATGTGA-3’) and 
reverse (5’-TGGCGACAAAGAATACACCA-3’) primers were designed flanking the 
predicted full-length coding region of the RECK gene. Total RNA was isolated from 
adult X. laevis lung tissue using a RNeasy Kit (Qiagen) according to manufacturer’s 
instructions. First-strand cDNA synthesis and PCR were performed on total RNA using 
qScript Reverse Transcriptase (Quanta Biosciences) and Kapa Hi-Fi Taq PCR Kit (Kapa 
Biosystems) according to manufacturer’s instructions. 
The putative X. tropicalis RECK sequence [XM_002938937.2] was only partial 
and lacked the signal peptide sequence at the 5’ end and the GPI-anchoring signal 
50 
 
sequence at the 3’ end of the gene. Therefore, the nested gene specific primers for the 5’ 
end (outer: 5’-ATGTGTCGTGATGTATGTGAACAG-3’ and  inner: 5’-CCTCCCTTAG 
TTCAGTGTGT-3’) and 3’ end (outer: 5’-CCTGCAATTCCTGTCACAG-3’ and inner: 
5’-CAACATGTCTCTGTACCTCAG-3’) were also generated to isolate the missing 
domains of X. laevis RECK using the FirstChoice RNA Ligase Mediated Rapid 
Amplification of cDNA Ends (RLM-RACE) Kit (Life Technologies) according to 
manufacturer’s instructions. The amplicons were cloned into the pCR 4-TOPO vector 
(Life Technologies) and sequenced at the DNA Sequencing Facility (Robarts Research, 
London, ON, Canada). The final amplification of the full-length coding region of 
X. laevis RECK was done using SuperTaq Plus (Life Technologies).  
2.2.3 Sequence Analysis 
The X. laevis RECK sequence obtained from PCR was translated using the 
ExPASy Bioinformatics Resource Portal online Translate tool 
(http://web.expasy.org/translate/). This X. laevis RECK sequence was submitted to 
genbank as [AIZ00509.1]. Other well-annotated, full-length RECK protein sequences at 
the time of publication along with the accession numbers used for comparison were from 
the following species: human Homo sapiens [NP_066934.1], chimp Pan troglodytes 
[XP_520575.2], rhesus monkey Macaca mulatta [XP_001083599.1], dog Canis lupus 
familiaris [NP_001002985.1], cow Bos taurus [NP_001179394.1], mouse Mus musculus 
[NP_057887.2], tiger Panthera tigris altaica [XP_007076663.1], alpaca Vicugna pacos 
[XP_006204234.1], little brown bat Myotis lucifugus [XP_006102759.1], 13 lined 
squirrel Ictidomys tridecemlineatus [XP_005326326.1], common shrew Sorex araneus 
[XP_004600290.1], fresh water dolphin Lipotes vexillifer [XP_007456041.1], platypus 
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Ornithorhynchus anatinus [XP_007661391.1], tasmanian devil Sarcophilus harrisii 
[XP_003761399.1], chicken Gallus gallus [XP_418897.4], penguin Pygoscelis adeliae 
[XP_009322770.1], bald eagle Haliaeetus leucocephalus [XP_010575445.1], ibis 
Nipponia nippon [XP_009473764.1], hummingbird Calypte anna [XP_008500730.1], 
pike Esox lucius [XP_010884005.1], croaker Larimichthys crocea [XP_010749852.1], 
zebra fish Danio rerio [XP_009295477.1], sole Cynoglossus semilaevis 
[XP_008305649.1], alligator Alligator sinensis [XP_006019052.1], soft shell turtle 
Pelodiscus sinensis [XP_006113101.1], frog X. tropicalis [XP_002938983.2], ghost 
shark Callorhinchus milii [XP_007896317.1], coelacanth Latimeria chalumnae 
[XP_006005911.1], fruit fly Drosophila melanogaster [NP_001261853.1], mosquito 
Anopheles gambiae [XP_311364.4].  
Full-length RECK amino acid sequences were aligned using Clustal Omega 
Multiple Sequence Alignment web software at the European Bioinformatics Institute 
(EBI) site (http://www.ebi.ac.uk/Tools/msa/clustalo/) and given a score based on 
similarity. The signal sequence, structural domains of RECK (cysteine knots and Kazal 
motifs), and GPI anchor were determined using the Simple Modular Architecture 
Research Tool (SMART) web software (at http://smart.embl.de/). All analyses were 
performed using default program settings.  
2.2.4 Immunohistochemistry and Fluorescence Microscopy 
Embryos were fixed in 3.7% paraformaldehyde in 1X phosphate-buffered saline 
(PBS) for 2 hours at room temperature. Fixed embryos were sent to the Molecular 
Pathology Core Facility at Robarts Research Institute (London, ON) for paraffin 
embedding and sectioning. 10 µm de-waxed sections were probed with primary antibody 
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(mouse anti-RECK, Santa Cruz, #sc-373929) followed by fluorescently-labeled 
secondary antibody (Alexa Fluor goat anti-mouse IgG, Life Technologies). Slides were 
mounted using ProLong Gold Antifade Mountant with 4’,6-diamidino-2-phenylindole 
(DAPI) (Life Technologies). Slides were visualized using a Leica automated inverted 
microscope.   
2.2.5 Morpholino Design 
The design and synthesis of MO were performed by Gene Tools (Philomath, OR). 
A translation-blocking MO (3’-CATCACATCCCCACTCCTTCTCTTC-5’) and 
splice-blocking MO (3’-CTTTTAGTTTGACTTACCAGGTGGT-5’) were engineered to 
target X. laevis RECK (GenBank, AIZ00509.1). A carboxyfluoresceinated-labelled 
translation-blocking MO targeted to the X. laevis β-catenin gene (3’-TTTCAACCGTTTC 
CAAAGAACCAGG-5’) was also purchased from Gene Tools as a control. 
2.2.6 Morpholino Microinjection 
Just fertilized X. laevis embryos were transferred from 0.1X Marc’s modified 
ringers (MMR) into 1X MMR containing 4% Ficoll. 2.3 nL (6 ng/nL) of splice-blocking 
RECK MO or translation-blocking RECK MO were microinjected at the 1-cell stage 
using 10 µm diameter glass needles. β-catenin MO (9 ng/nL) was used as a positive 
control, and water-injected and un-injected embryos were used as negative controls. 
Embryos were maintained in 1X MMR with Ficoll for 6 hours following injection, then 
transferred to 0.1X MMR solution for rearing. Any dead or abnormal embryos 2 hours 
post-injection were removed, and the remaining embryos were examined for phenotypic 
abnormalities. Embryos were analyzed for 3 days following injection. Images of embryos 
were taken using an Olympus SXZ9 microscope with a Nikon camera attachment.  
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2.2.7 Immunoblot Analysis 
RECK-MO injected and un-injected embryos from 1 dpf were collected, 1 embryo 
each, and homogenized in 50 µL of radioimmunoprecipitation assay (RIPA) buffer 
supplemented with phosphatase/protease inhibitors (Thermo Scientific). Protein extracts 
were centrifuged at 12,000 g at 4°C for 30 minutes and the supernatant was collected. 
Protein extracts were run on a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel and 
transferred to a polyvinylidene fluoride (PVDF) membrane. Membranes were blocked 
with 0.5% bovine serum albumin (BSA) (Fisher Scientific) in tris-buffered saline with 
Tween-20 (TBST) (pH 7.5) for 30 minutes at room temperature and incubated overnight 
at 4°C with primary antibody (RECK, 1:200, Cell Signaling Technology, #3433; β-actin, 
1:1000, Santa Cruz, #sc-47778) followed by 1 hour incubation at room temperature with 
either horseradish peroxidase (HRP)-labeled goat anti-rabbit or anti-mouse secondary 
antibodies (Thermo Fisher Scientific) diluted 1:10,000 in blocking solution. Signal was 
detected using a SuperSignal Chemiluminescent kit (Thermo Scientific) as per the 
manufacturer’s instructions. Blots were visualized using the Bio-Rad ChemiDoc Imaging 
system.  
2.2.8 Quantitative Real-Time PCR 
To investigate changes in developmental marker genes and ECM remodeling 
genes, quantitative real-time PCR was performed. 10 embryos at 1 dpf were collected 
from RECK MO-injected and un-injected embryos. Total RNA was isolated using an 
RNeasy Mini kit (Qiagen) according to manufacturer’s instructions. cDNA was 
synthesized from 1 µg of RNA using qScriptTM CDNA SuperMix (Quanta) according to 
manufacturer’s instructions. qPCR was carried out using SYBR Green PCR Master Mix 
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(Applied Biosystems). For quantification, the X. laevis target genes (RECK 5’-ATGGCG 
GCGGTCCCGGCCTC-3’ and 5’-ATGTGTCGTGATGTATGTGAACAG-3’, chordin 
5’-AACTGCCAGGACTGGATGGT-3’ and 5’-GAAGCAACTCTAAATCCTGCC-3’, 
XCG 5’-CTGTACTGGTTCACCAATAATCCC-3’ and  5’-GTGAGACGACTGCAATG 
TAGC-3’, FoxD3 5’-TCTCTGGGGCAATCACACTC-3’  and 5’-CCCTTTATCAACAA 
ATGTAC-3’, Xnot1 5’-GCAGGCAGAGTTCAGTTGTG-3’ and 5’-CCACAGGCAAAG 
CAACTCAC-3’,  ß-catenin 5’-CCCGATGAATCTGCATTGTGA-3’ and 5’-GCAAGCT 
GGAACTTATCAG-3’, MMP-2 5’-CAGGGAATGAGTACTGGGTCTATT-3’ and 5’-G 
TAGATGCTGCCTTTAACTGGAGT-3’, MMP-9 5’-AATCTCTTCTAGAGACTGGGA 
AGGAG-3’  and 5’-TCCAGCTACTTTAGTCAATCAGCT-3’, MT1-MMP 5’-CATGGG 
CAGCGATGAAGTCT-3’  and 5’-TACTTCTACAAGGGGAACAAATACTGG-3’, and 
TIMP-2  5’-GCCCCCGCCCGCCCAGCC-3’  and 5’-TCGGCAGTGTGTGGGGTCTCG 
GGA-3’) were  normalized to  the internal  standard of elongation factor one alpha (EF1α 
5’-CAGATTGGTGCTGGATATGC-3’    and    5’-CTAGGAGTCATCAAGGCAGT-3’) 
(Krieg et al., 1998). The amplification was calculated according to the ∆∆CT method 
(Livak and Schmittgen, 2001). 
2.2.9 Statistical Analysis 
Statistical analysis and graphing were performed using Microsoft Excel. Data is 
presented as ± standard error of the mean (SEM). One-way analysis of variance 
(ANOVA) followed by unpaired student’s T-tests were used. The different levels of 
significance are denoted as follows: ns, p>0.05; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001. 
2.3 Results and Discussion  
2.3.1 Sequence Analysis 
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Since no record existed to date, I began by cloning and sequencing X. laevis 
RECK. The full-length coding region of X. laevis RECK was amplified from adult lung 
tissue RNA by PCR using primers designed against the X. tropicalis RECK sequence 
[XM_002938937.2] and 5’ and 3’ RACE. The putative X. laevis RECK full-length 
mRNA sequence was submitted to GenBank with accession # [AIZ00509.1] (Appendix 
B). The derived X. laevis RECK had a full-length coding region of 2,904 bp and a 
predicted protein length of 967 amino acids (Fig. 2.1a). SMART domain analysis of X. 
laevis RECK was used to identify the hallmark protein domains characteristic of other 
RECK proteins (Fig. 2.1a). This included an N-terminal signal sequence and a C-terminal 
GPI anchor signal - both of which are removed in the mature protein. Also present were 5 
characteristic cysteine knot motifs and 3 Kazal inhibitory domains. I then analyzed the 
predicted X. laevis RECK protein sequence along with RECK sequences from both 
vertebrate and insect species. Clustal Omega was used to align various RECK protein 
sequences, and conserved amino acids that were identical for all animals were counted 
(Table 2.1). Conserved RECK amino acid sequences were examined in all 31 animals 
selected at the time of publication. RECK proteins had a 33% and higher amino acid 
identity when compared across all vertebrates and insects. Vertebrate RECK amino acids 
were 58% and higher identical, with fish, herptile and mammalian RECK being 68%, 
75% and 85% and higher identical within each group. The selected bird RECK amino 
acids showed the most identity with a conservation of 93% and higher.  
Hallmark domains of RECK were further analyzed to determine conservation 
within RECK proteins that may reveal important domain functions. One of the hallmark 
domains  of   all  RECK  proteins  is  3  protease  inhibitor-like  domains  (Kazal  motifs).  
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Figure 2.1 X. laevis RECK amino acid sequence  
(a) X. laevis RECK is 967 amino acids in length and contains an N-terminus signal 
sequence and a C-terminus GPI-anchoring sequence (bold and italic). The N-terminal 
region of RECK contains 5 repeats of a putative cysteine knot motif (underlined). The 
middle portion of RECK contains a highly conserved 32 amino acid stretch I termed a 
LAD-RSC domain (dashed underline). 3 Kazal motifs serine-protease inhibitor-like 
domains (wavy underline) are found towards the C-terminus. (b) Amino acid sequence of 
the described X. laevis RECK LAD-RSC domain and its Clustal Omega alignment with 
other select animals. Star (*): identical amino acids are found in all sequences, colon (:): 
strong similarity, period (.): weak similarity.  
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(a) Predicted X. laevis RECK amino acid sequence 
 
MKRRSGDVMHAAVRVMSASASCLGLLGIWFFLLIFLLLEAADASCCNQAKDNLMCRDVC
EQILSSKSESRIKHLLLRAPDYCPTSMIDVWTCINSSLPGVSKKSEGWVGLGCCELAIA
VECRRACKQASSQNDISKSCRKQYETALISCINRNEMGSVCCSYAGRHTNCREYCQAIF
RTDSSPGPSQIKAVENFCASISPPLVQCVNNYTQSYPMRNPVDSLYCCDRAEDPQCQSA
CKRILMSKKTEPEIVDSLSEGCTKPLPQDPLWQCFLESSRTVHSGVNIVPPPSAGLDGA
ELHCCSKANSSNCRDLCTKLYSTSWGNTQVWQEFEFACEYNPLEAPMLTCLADVREPCQ
LGCRNLTFCTNFNNRPTELFRSCNVQSDQGAMNDMKLWEKGSIKMPFMNIPVLDIKKCH
PEMWKAIACSLQIKPCHSKSRGSIICKTDCVEILTKCGDHSRFPESHTAESICELLSPS
DENEDCIPLDTYLRSSPLDNAIEEVTHPCNPNPCPANHLCEVNRKGCLPGEPCLPYFCS
QGCKLGETSDFLVRHGVLIQMPSGSVGCYKICTCGQSGTLENCLDMQCVDLHKSCLVGG
QRKNHGESFKVDCNICSCVAGTLRCSNHQCPHSEEDRRMFTGLPCNCEDQFVPVCGQNG
RTYPSACIARCVGLLDHQFEFGLCSSVCNPNPCSRNGIPKRKVCLTSYEKFGCAQYECI
PRHLKCEHSRDPMCDTENVEHINLCTLYQRGRLLSYKGSCQPFCKSAEPVCGHNGETYP
NVCSAYSDRVAVDYYGHCQDVGIFSDQGLHNECLSIQCPAIPVTVCKPIIPPGACCPLC
AGVLRILFDKEKLDTFATATKNTPITVMDILQKIRQHVSVPQCDVFGYLSMESDIIILI
VPVDSPPKSIQIDACNKEAEKINSLINSDSPTLVSQVPLSALITSEVQVSTTLNSDCNR
ICLSIHYIYLYLGIALLYVTLNA 
 
(b) LAD-RSC domain conservation 
 
zebra fish  LADVREPCQLGCKELSYCTNFNNRPTELFRSC 
coelacanth  LADVREPCQLGCKDLTFCTNFNNRPTELFRSC 
x laevis    LADVREPCQLGCRNLTFCTNFNNRPTELFRSC 
chicken     LADVREPCQLGCRNLSYCTNFNNRPTELFRSC 
hummingbird LADVREPCQLGCRNLTYCTNFNNRPTELFRSC 
platypus    LADVREPCQLGCRNLTFCTNFNNRPTELFRSC 
human       LADVREPCQLGCRNLTYCTNFNNRPTELFRSC 
fruit fly   IESVDAPCELGCQGLSFCSNFNNRPTELFRSC 
mosquito    IDEVDEPCELGCDGLSFCSNFNNRPTELFRSC 
            : .*  **:***  * :*:************* 
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According to Takahashi et al. (1998) only the first domain in human RECK completely 
matches a Kazal motif sequence, whereas the 2nd and 3rd domains contain partial Kazal 
motif sequences. A recently published in silico search of nucleotide databases revealed 
the presence of members of the Kazal-family in the 4 major subphyla of the Arthropoda 
(van Hoef et al., 2013). While most insect Kazal motifs contain the 6 cysteines that are 
characteristic to this domain and are responsible for the formation of 1-5, 2-4, and 3-6 
disulfide bridges between the 6 cysteines, only Kazal motif 1 has these 6 cysteines in 
vertebrates. This conserved presence of Kazal domains in animals that have very diverse 
developmental histories also suggests that such proteins may also play important roles in 
general tissue maintenance, as well as in developmental processes. While SMART 
domain analysis of X. laevis RECK identified only 2 Kazal motif domains (this is the 
same for X. tropicalis and Drosophila RECK proteins), my analysis showed that all 3 
Kazal motif domains are highly conserved and contain conserved cysteines. In agreement 
with Takahashi et al. (1998), who suggested that the 1st domain best matches a classic 
Kazal motif sequence, the 1st Kazal motif is best conserved in all animals and within 
animal groups. Moreover, all vertebrate Kazal motifs contain the same number of amino 
acids between conserved cysteines among all species examined (Appendix C). The 
conservation of all cysteines in all motifs suggests that the 2 partial Kazal motifs also 
contribute an important function to the protein in vertebrates. As the Kazal motifs are 
protease inhibitor-like domains and play an important role in inhibiting MMPs (Chang et 
al., 2008), the consistent high conservation of Kazal motif 1, and the presence of 3 such 
domains in all vertebrates, suggests a conservation of RECK function as an MMP 
inhibitor in these species.  
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The N-terminal region of RECK contains 5 large repeats of a cysteine knot motif. 
Collectively, these 5 putative cysteine knot motifs share relatively moderate similarity 
among all animals (17-23%) with higher conservation of identity being seen in 
vertebrates and the subgroups examined, with the most striking conservation of these 
domains being in birds (Table 2.1). While in general it was cysteine knot 3 and 4 that 
were the most conserved, all knot motifs in all animals had 6 conserved cysteines. This 
included 2 cysteines at the beginning of each knot, a gap of 7 or 8 amino acids, followed 
by the 3rd cysteine with 3 or 4 amino acids before cysteine 4. The conservation of 6 
cysteines in 5 knots in all animals, with the spacing of the first 4 cysteines being almost 
identical in animals ranging from insects to amphibians to mammals is quite remarkable. 
The conservation in the number of cysteines and their spacing, but the dissimilarity in 
amino acids between the cysteines, suggests that these motifs play structural roles that are 
important to the overall functions of folded RECK proteins. While the overall RECK 
protein displays high levels of sequence conservation, analysis revealed a 32 amino acid 
sequence following the 5th cysteine knot that was the most conserved of any other region 
of the protein. I have termed this region a LAD-RSC domain based on the first 3 (LAD) 
and last 3 (RSC) amino acids. This stretch of amino acids shares no sequence similarity 
with any characterized functional domain to date. This stretch of amino acids is, however, 
68% identical between all of the animals I investigated, 88% identical in vertebrates, and 
over 90% identical within the various vertebrate sub-groups. While domains such as the 
cysteine knot and Kazal motifs are hallmarks of RECK, these hallmark domains make up 
only a portion of its almost 1,000 amino acid sequence. The high conservation of other 
regions, such as the LAD-RSC domain, suggest novel and as yet to be characterized roles 
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for RECK, such as its roles in cell signaling (Walsh et al., 2015) - functions that are 
MMP-independent and thus may not involve the Kazal motifs.  
2.3.2 RECK Protein Localization 
As previous research has demonstrated both a neural and vascular role for RECK 
during development of fish and mouse (Oh et al., 2001; Prendergast et al., 2012), I sought 
to investigate if a similar embryonic expression pattern existed for X. laevis RECK. My 
previous in situ analysis revealed that RECK transcripts are present in dorsal neural 
structures and the head region, such as the branchial arches, in early tailbud (stage 24) 
embryos (Willson et al., 2015). To confirm neural and branchial arch RECK localization, 
IHC was performed to localize RECK proteins on histological sections of late tailbud 
(stage 28) embryos (Fig. 2.2). Punctate staining of RECK proteins was present in the 
dorsal side of the neural tube (Fib. 2.2b). In the head region of late tailbud embryos, 
RECK proteins were localized in the area of the branchial arches (Fig. 2.2d). RECK 
presence in neural structures and branchial arch regions of the developing X. laevis 
embryo is similar to that observed in zebrafish embryos, and consistent with the finding 
that RECK plays an important role in the differentiation of neural crest cells into the 
DRG (Prendergast et al., 2012). Additionally, the expression of RECK in anterior 
structures coincides with the expression of ECM proteinases (stromelysin-3 and 
ADAM-19) (Damjanovski et al., 2001; Neuner et al., 2009), and TIMPs (Pickard and 
Damjanovski, 2004), reflecting the complex regulation of the ECM remodeling events 
occurring in these anterior tissues. Further, RECK presence in the area of the branchial 
arches, which will contribute to the formation of the gills, is consistent with a role for 
RECK in vascular development as its localization is consistent with Xfli1, whose similar 
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Figure 2.2 Localization of RECK proteins in late tailbud embryos.  
IHC was performed on sections of late tailbud embryos to detect RECK protein (red). 
(a), (c) Brightfield differential interference contrast (DIC) images are shown. (b) RECK 
proteins are localized on the dorsal side of the neural tube and dorsal fin. (d) RECK 
proteins are localized in regions consistent with branchial arches.  
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expression demarks endothelial cell differentiation (Ciau-Uitz et al., 2000). 
2.3.3 Functional Analysis 
2.3.3.1 RECK Knockdown in X. laevis Embryos Causes Developmental 
Defects 
To investigate the effects of disrupting RECK expression during X. laevis 
embryogenesis, RECK MO were microinjected into 1-cell stage embryos. β-catenin 
MO-injected, water-injected, and un-injected embryos were used as controls. Both a 
translation-blocking RECK MO and splice-blocking RECK MO were used to verify 
RECK knockdown phenotypes. Confirmation of RECK knockdown using each MO was 
confirmed by either Western blotting or qPCR (Fig. 2.3). Embryos were analyzed for 
morphological changes in development for 3 days following RECK MO injection. The 
percent survival was determined and quantified 1 dpf (st 24) and 2 dpf (st 30) (Fig. 2.4). 
Over 90% of control embryos (un-injected and water-injected) developed normally, 
whereas approximately 60% of RECK MO-injected embryos survived to 2 dpf (Fig. 2.4). 
The surviving RECK MO-injected embryos successfully underwent gastrulation, 
however, they showed severe developmental defects, including neural tube closure failure 
at 1 dpf (Fig. 2.5b) axial defects and curvature at 2 dpf (Fig. 2.5d), and reduced head 
structures and yolk reduction at 3 dpf (Fig. 2.5f). 
My IHC analysis had revealed that RECK proteins are localized to the neural tube 
and head region (Fig. 2.2). The phenotypic defects of the dorsal axis seen in RECK 
MO-injected embryos coincide with the expression pattern of RECK during normal 
development (Fig. 2.2). Neurulation requires tightly coordinated cell movements and 
timed   interactions  of  germ  layer  tissues,  that  of   which  also   rely  on  proper   ECM  
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Figure 2.3 Microinjection of RECK translation-blocking or splice-blocking MO 
decreased RECK levels in X. laevis embryos. 
(a) Following injection of RECK translation-blocking MO (6 ng/nL) at the 1 cell stage, 
protein was isolated from both RECK-MO injected and un-injected embryos 1 dpf. 
Knockdown of RECK (110 kDa) protein occurred in RECK MO-injected embryos. 
β-actin (42 kDa) was used as a loading control. (b) Following injection of RECK 
splice-blocking MO (6 ng/nL) at the 1-cell stage, RNA was isolated from embryos 1 dpf. 
RECK RNA levels were reduced in RECK MO-injected embryos compared to control. 
Results are based on 3 biological replicates (mean ± SEM; technical replicates, N=9). 
Data is analyzed via t-test; ***, p≤0.001.  
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Figure 2.4 RECK knockdown embryos displayed reduced survival. 
2.3 nl (6 ng/nL) of RECK MO was injected into X. laevis embryos at the 1-cell stage. 
Following injection, embryos were scored for a normal phenotype 1 and 2 dpf. The 
percent of embryos that survived following injection is graphed. Results are based on the 
average of 3 biological replicates, where a minimum of 100 embryos were injected and 
counted for each replicate. Bars indicate standard error (SE).  
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Figure 2.5 RECK knockdown resulted in developmental defects.  
RECK MO (6 ng/nL) were injected into X. laevis embryos at the 1-cell stage. Following 
injection, embryos were scored for a normal phenotype 1, 2, and 3 dpf. Following 
injection, photographs were taken of representative embryos. Un-injected embryos were 
phenotypically normal (a,c,e). Knockdown of RECK caused neural tube closure failure at 
1 dpf (b), axial defects and curvature at 2 dpf (d), and head defects at 3 dpf (f). 
Abbreviations: A=anterior, CG=cement gland, H=head, NF=neural tube closure failure, 
P=posterior.    
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remodeling (Nikolopoulou et al., 2017).  Failure of the neural tube to close can arise from 
defects in cell movement as well as cell fate determination (Nikolopoulou et al., 2017). 
RECK MO-injected embryos observed at stage 20 (neurula stage) exhibited a truncated 
and twisted axis, with delayed neural tube fusion (Fig. 2.5b) (Appendix D). Predictably, 
the failure of the neural tube to close will lead to abnormal head development in 
subsequent stages, as was seen in RECK MO-injected embryos at 3 dpf (Fig. 2.5f).  
The embryos that survived to 2 dpf (about 61%) exhibited axial defects and 
delayed development (Fig. 2.5d). By 3 dpf (stage 40), the full effects of RECK 
knockdown were evident. RECK MO-injected embryos exhibited a curved dorsal axis 
and reduced yolk endoderm (Fig. 2.5f). RECK MO-injected embryos also exhibited 
reduced head structures, such as the eye, however, the development of the cement gland 
was unaffected (Fig. 2.5f).  The cement gland is the first fully developed and most 
anterior organ in the embryo and is a visual indicator that embryos have successfully 
completed gastrulation (Sive and Bradley, 1996). At 3 dpf, RECK MO-injected embryos 
also exhibited abnormal swelling on the ventral-lateral sides of their bodies (Fig. 2.5f). 
This could be an indication of poor development of the vasculature due to RECK 
knockdown, as RECK proteins were localized in the branchial arches in normally 
developed embryos (Fig. 2.2), and RECK has previously been shown to play a role in 
vascular development (Oh et al., 2001; Prendergast et al., 2012). Moreover, reduced head 
structures observed in RECK MO-injected embryos at 3 dpf could also be attributed to 
defects in neural crest cell migration. Neural crest cells contribute to a variety of 
structures in the body, including craniofacial bones and cartilage, smooth muscle, and 
many peripheral neurons (Mayor and Theveneau, 2013). Indeed, Prendergast et al. (2012) 
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have previously shown RECK as an important modulator during neural crest cell 
migration in zebrafish.    
2.3.3.2 Real-Time PCR Analysis of Developmental Marker Genes in 
RECK MO-Injected Embryos 
To understand the morphological phenotypes observed in RECK MO-injected 
embryos, real-time qPCR was performed on key developmental marker genes (chordin, 
Xnot1, FoxD3, β-catenin, and XCG) at 1 dpf (stage 20). RECK MO-injected embryos at 
stage 20 (1 dpf) had a significant increase in chordin mRNA levels compared to 
un-injected embryos (Fig. 2.6). The chordin gene encodes a dorsal organizing protein, 
important for patterning the dorsoventral axis and inducing neural structures (Sasai et al., 
1994). Xnot1 is a dorsal marker that acts upstream of chordin and plays a fundamental 
role in notochord formation (Fujimi et al., 2012). FoxD3 encodes a transcription factor 
important in the determination, migration, and differentiation of neural crest cells 
(Cheung et al., 2005; Dottori et al., 2001; Sasai et al., 2001). The significant change seen 
in chordin transcript levels coincide with the neural tube defects that occurred in RECK 
MO-injected embryos. The increase in chordin mRNA levels would subsequently cause 
an increase in the delineated border of cells that could give rise to the neural crest, which 
would subsequently require more Xnot1 and FoxD3 transcription to give rise to neural 
crest cells. Therefore, RECK MO-injected embryos may have increased the number of 
neural crest cells that could potentially, but do not actually, migrate due to RECK 
knockdown. This may offer an explanation to the effects of neural tube closure failure, 
subsequent twisting and curving of the dorsal axis, and reduced head structures. In fact, 
my results are consistent with past studies that have implicated RECK to be important 
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Figure 2.6 Effect of RECK knockdown on transcript levels.  
Effect of RECK knockdown on transcript levels. Real-time qPCR was used to measure 
the changes in transcript levels following injection of 6 ng/nL of RECK MO into X. laevis 
embryos at the 1-cell stage. Changes in transcript levels were measured relative to EF1⍺ 
and normalized to control (un-injected) embryos (set to 1). Results are based on the 
average of 3 biological replicates (mean ± SE; technical replicates, N=9). Data is 
analyzed via t-test: *, p≤0.05.    
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during neural crest cell migration (Prendergast et al., 2012) and neurogenesis (Muraguchi 
et al., 2007). β-catenin (a marker for gastrulation initiation) and XCG (cement gland 
marker) levels did not change in RECK MO-injected embryos compared to control (Fig. 
2.6), as expected, as RECK MO-injected embryos successfully underwent gastrulation.  
2.3.3.3 Real-Time qPCR Analysis of ECM Remodeling Genes in RECK 
MO-Injected Embryos 
To further understand the morphological phenotypes observed in RECK 
MO-injected embryos, real-time qPCR was performed on ECM remodeling genes that 
have previously been associated with RECK function (MT1-MMP, MMP-2, MMP-9, and 
TIMP-2) 1 dpf. RECK MO-injected embryos at stage 20 (1 dpf) had a significant increase 
in MT1-MMP mRNA levels and a significant decrease in MMP-2 and TIMP-2 mRNA 
levels compared to control (un-injected) embryos (Fig. 2.6). MMP-9 mRNA levels also 
changed; however, the increase was not significant compared to control embryos 
(Fig. 2.6).  
MT1-MMP expression is activated early during X. laevis development at the 
gastrula stage, and multiple studies have noted severe developmental defects following 
disruption of endogenous MT1-MMP levels during development (Hasebe et al., 2007; 
Holmbeck et al., 1999; Zhou et al., 2000). Interestingly, overexpression of MT1-MMP in 
X. laevis embryos led to a similar curved dorsal axis phenotype (Hasebe et al., 2007) as I 
saw in RECK MO-injected embryos (Fig. 2.5). My real-time qPCR results indicated a 
significant increase in MT1-MMP transcript levels following RECK knockdown (Fig. 
2.6), therefore, the morphological defects observed in RECK MO-injected embryos could 
be attributed to aberrant up-regulation of MT1-MMP expression. Indeed, RECK is a 
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known inhibitor of MT1-MMP activity in vitro (Oh et al., 2001), and therefore may also 
play an important MMP-inhibitory role during X. laevis development as well. 
TIMP-2 is expressed from the neural stage onwards during X. laevis development. 
TIMP-2 also plays an important role during development. Overexpression of TIMP-2 in 
X. laevis embryos results in severe developmental defects, including neural tube closure 
failure and axial defects (Nieuwesteeg et al., 2012), similar to what I saw in RECK 
MO-injected embryos (Fig. 2.5). I saw a significant decrease in TIMP-2 mRNA in RECK 
MO-injected embryos compared to control (Fig. 2.6), which further implies a disruption 
occurred in the balance between MMPs and their inhibitors in RECK MO-injected 
embryos that led to developmental defects.  
It is difficult to determine the exact molecular mechanisms impacted by RECK 
knockdown that led to these specific developmental defects. However, the changes that 
occurred in the levels of ECM remodeling genes (MT1-MMP and TIMP-2), suggest that 
RECK expression is a critical factor in regulating cell-ECM interactions during X. laevis 
development. 
2.4 Conclusions 
This study has revealed the important developmental roles of RECK by 
demonstrating its high level of evolutionary sequence conservation, developmental 
localization, and functional importance. All examined animal RECK amino acid 
sequences contain all hallmark domains. IHC analysis of RECK during early X. laevis 
development revealed that RECK is present in dorsal and anterior structures such as the 
neural tube and head region. Disrupting endogenous levels of RECK using a MO 
approach in X. laevis embryos resulted in specific developmental phenotypes, including 
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neural tube closure failure, axial defects, and reduced head formation. Neural tube 
closure defects were further analyzed by real-time qPCR. Significant increases in chordin 
mRNA levels suggest RECK knockdown impacts neural tube closure and subsequent 
neural crest cell migration. Changes in important ECM remodeling genes (MT1-MMP, 
MMP-2, and TIMP-2), also propose a possible explanation for the observed phenotypic 
defects seen in RECK MO-injected embryos that may relate to improper ECM 
degradation and remodeling. My results suggest that during X. laevis development, 
RECK is an important player in neural tube closure and dorsal axis patterning.   
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Chapter 3  
3 Spatial Analysis of RECK, MT1-MMP, and TIMP-2 Proteins 
During Early Xenopus laevis Development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work has previously been published as: “Willson, J.A., Damjanovski, S. (2019). 
Spatial analysis of RECK, MT1-MMP, and TIMP-2 proteins during early Xenopus laevis 
development. Gene Expression Patterns. 34: 119066.” As per Elsevier B.V., I retain or 
am hereby granted (without the need to obtain further permission) the Author Rights. The 
text has been modified from the original manuscript to adhere to formatting guidelines 
for this thesis. Experiments were designed and carried out by J.A.W., and S.D. provided 
funding, resources, and intellectual contributions.   
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3.1 Introduction 
MMPs have long been classified as crucial players during vertebrate development 
due to their ability to cleave components of the ECM (Visse and Nagase, 2003). 
24 vertebrate MMPs have been characterized and divided into 2 distinct categories: 
secreted or MT-MMPs. Each MMP has a specific substrate specificity, carrying out 
distinct functions during ECM remodeling (Visse and Nagase, 2003). During 
development MMPs facilitate extensive and necessary ECM remodeling events that allow 
large-scale cell rearrangements and alter cell signaling. This ECM remodeling is 
required, as aberrant up-regulation of MMPs has been associated with developmental 
defects and death. Indeed, previous work with transgenic X. laevis embryos demonstrated 
that overexpression of the MMPs - collagenase 4 (MMP-18) or stromelysin 3 (MMP-11) 
- resulted in embryonic lethality (Damjanovski et al., 2001). Therefore, a delicate balance 
exists between the levels of MMPs and their endogenous inhibitors, TIMPs and RECK. 
Severe developmental defects have been observed when this balance is shifted towards 
MMP inhibition via TIMP-2 overexpression during early X. laevis development 
(Nieuwesteeg et al., 2012). While much research has examined MMP and inhibitor 
activity levels with respect to large-scale cell movements, less is known about 
interactions modulating cell signaling events, particularly interactions involving 
pericellular molecules such as RECK, MT1-MMP, and TIMP-2. 
 MT1-MMP is unique in that of all MMPs only MT1-MMP null mice resulted in 
death, with neonatal mice dying by 12 weeks of age due to severe skeletal and 
vascularization defects (Holmbeck et al., 1999; Zhou et al., 2000). As a transmembrane 
protein, MT1-MMP not only remodels the surrounding milieu, but can also interact with 
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nearby cell surface receptors and facilitate intracellular signaling cascades (Deryugina et 
al., 2002; Kajita et al., 2001; Seiki, 2002). A well-characterized function of MT1-MMP is 
its ability to activate pro-MMP-2, a potent protease, in coordination with TIMP-2 
(Fig. 1.2). TIMP-2 is unique as it remains more proximal to the cell surface in 
comparison to the other 3 secreted TIMPs (Itoh et al., 2001).  
 RECK is another inhibitor of MMPs and is present on the cell surface as a 
GPI-anchored protein (Oh et al., 2001; Takagi et al., 2009; Takahashi et al., 1998). 
Expression of RECK during development is crucial, as RECK null mice were embryonic 
lethal due to severe vascular defects, in part due to altered MMP activity (Chandana et 
al., 2010; Oh et al., 2001). In vitro studies have shown that RECK not only attenuates the 
proteolytic activity of MT1-MMP, but it can also modulate its endocytosis from the cell 
surface (Miki et al., 2007), again demonstrating the functional importance of the 
pericellular colocalization of these proteins.  
MMPs, TIMPs, and RECK all play a crucial role during events that require 
extensive ECM remodeling, such as during development and tissue repair (Lemaitre and 
D’Armiento, 2006; McCawley and Matrisian, 2001; Visse and Nagase, 2003; Willson 
and Damjanovski, 2014). Past studies have examined the roles of MMPs and their 
inhibitors during early embryonic processes (Alexander et al., 1996; Balbı́n et al., 2001; 
Pagenstecher et al., 1997; Prendergast et al., 2012; Wilson et al., 1995). Nuttall et al. 
(2004) were the first to characterize the expression pattern of every mouse MMP, TIMP, 
and RECK gene in different tissues throughout mouse development using qPCR analysis. 
They reported high RNA levels of MT-MMPs and TIMPs, and low levels of secreted 
MMPs, in most differentiated tissues, though they did not examine protein localization.   
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In vitro studies have been carried out to show that MT1-MMP interacts 
individually with RECK and TIMP-2 on the cell surface (Itoh et al., 2001; Miki et al., 
2007). Toward furthering our understanding of their roles in vivo, in this chapter I 
investigated the localization of these 3 proteins throughout early development using IHC. 
At different developmental time points (neurulation, axis elongation, and organogenesis - 
stages 17-38), RECK, MT1-MMP, and TIMP-2 proteins show strikingly similar 
localization patterns, particularly in their shifting localization from the dorsal to ventral 
sides of the neural tube, and in the differentiating somite, suggesting they may function 
together during specific patterning processes throughout early X. laevis development.   
3.2 Materials and Methods 
3.2.1 Animal Care and Rearing 
Adult X. laevis were purchased from Xenopus 1, Inc (Dexter, MI). Animal rearing 
and fertilizations were carried out as described in Section 2.2.1.   
3.2.2 Immunohistochemistry and Fluorescence Microscopy 
Embryos at stages 17, 20, 28, 34, and 38 (Fig. 1.6) were fixed as described in 
Section 2.2.4. Fixed embryos were sent to the Molecular Pathology Core Facility at 
Robarts Research Institute (London, ON) for paraffin embedding and sectioning. 
Transverse sections (10 µm apart) were made either along the mid anterior-posterior axis 
or in the anterior head region (as illustrated in Supplementary Fig. S3.1).  De-waxed 
sections were probed with primary antibody (mouse anti-RECK, Santa Cruz, #sc-373929; 
rabbit anti-RECK, Santa Cruz, #sc-28918; rabbit anti-MT1-MMP, Santa Cruz, 
#sc-30074; mouse anti-TIMP2, Santa Cruz, #sc21735) diluted 1:100 followed by 
fluorescently labeled secondary antibody (Alexa Fluor goat anti-mouse and anti-rabbit 
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IgG, Thermo Fisher Scientific) diluted 1:200. Slides were mounted as described in 
Section 2.2.4. Antibody validation for rabbit anti-RECK, rabbit anti-MT1-MMP, and 
mouse anti-TIMP-2 was performed using Western blotting with either X. laevis whole 
embryo lysate or X. laevis A6 cell lysate (Supplementary Fig. S3.2). Of note, the epitope 
region of mouse anti-TIMP-2 shares 82% sequence identity with the X. laevis TIMP-2 
amino acid sequence. Serial sections were probed with pairs of antibodies: RECK with 
MT1-MMP, RECK with TIMP-2, and TIMP-2 with MT1-MMP. Thus, the fidelity of an 
antibody’s localization could be confirmed across 2 colocalization studies. Negative 
controls, following the above protocol, but without primary antibody, were performed to 
analyze nonspecific binding of the secondary antibody (Supplementary Fig. S3.3). Slides 
were visualized using a Leica DM16000 B microscope with Hamamatsu camera 
controller (C10600) using Leica automated inverted microscope and analyzed using 
Image J 2.0.0 software (NIH, Bethesda). 4 sections per embryo, from 3 embryos per stage 
were analyzed for each pair of antibodies. Images are representative of 1 section from 
1 embryo; however, consistent staining patterns were seen between the sections from 
each embryo.  
3.3 Results and Discussion 
To determine the spatial expression patterns of X. laevis RECK, MT1-MMP, and 
TIMP-2 proteins during development, IHC was performed on mid-anterior/posterior (AP) 
axis transverse sections of embryos (the position as illustrated in Supplementary 
Fig. S3.1a,b). Transverse sections through the head region on stage 38 embryos were also 
examined (the position as illustrated in Supplementary Fig. S3.1c). Stages examined 
included 17-20, representing neural tube closure; 28-34, tailbud stages during which axial 
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elongation is accompanied by neural and mesodermal patterning; and stage 38, when 
nerve and muscle cells are differentiating, and organ formation is occurring, most notably 
the eye and heart (Fig. 1.6). Because RECK, MT1-MMP, and TIMP-2 mRNA transcript 
levels are low prior to and during gastrulation in X. laevis (Hasebe et al., 2007; Willson et 
al., 2015), I decided to begin my analysis following gastrulation. Of note, 2 primary 
RECK antibodies (mouse anti-RECK (red) and rabbit anti-RECK (green)) were used to 
verify the validity of RECK localization by probing sections with both antibodies 
(Supplementary Fig. S3.3). A negative control omitting primary antibodies was also 
performed to demonstrate specificity (Supplementary Fig. S3.3).  
3.3.1 RECK Localization During Early X. laevis Development 
I have previously shown through whole mount in situ hybridization that X. laevis 
RECK mRNA is present in tailbud embryos in dorsal axial structures, including the 
neural tube and the eye (Willson et al., 2015). My previous analysis of RECK protein 
localization using IHC on stage 28 embryos demonstrated neural and branchial arch 
localization (Fig. 2.2). To expand on these results, here I examined RECK protein 
localization, together with MT1-MMP and TIMP-2, throughout early X. laevis 
development from stages 17 to 38.  
 During neural plate bending (stage 17), there was broad but weak punctate RECK 
staining unassociated with specific regions (Fig. 3.1A2, 3.2A2), suggesting RECK does 
not have a distinct localization in any tissue at this stage. However, at stage 20, when the 
neural tube has just closed and is beginning to elongate, RECK localization was distinct 
with robust staining appearing along epidermal tissues as well as along the dorsal side of 
the neural tube (Fig. 3.1B2, 3.2B2). Since the neural crest resides on the dorsal side of the 
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Figure 3.1. Localization of RECK and MT1-MMP proteins during early X. laevis 
development. 
IHC was performed using Alexa Fluor 555-labeled anti-RECK (red) and Alexa Fluor 
488-labeled anti MT1-MMP (green) antibodies on stage 17-38 embryos. Brightfield DIC 
images are shown in the left panel. Mono-colour images for RECK and MT1-MMP are 
presented individually. Colocalization of RECK and MT1-MMP (yellow) is shown on the 
right panel. Dotted line in stage 28 merged image indicates overlapping signal within the 
middle of somites. Dashed line in stages 34 and 38 merged images indicates overlapping 
signal along the ventral neural tube. Scale bar= 100 µm. Abbreviations: E=endoderm, 
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural 
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT. 
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Figure 3.2. Localization of RECK and TIMP-2 proteins during early X. laevis 
development. 
IHC was performed using Alexa Fluor 488-labeled anti RECK (green) and Alexa Fluor 
555-labeled anti-TIMP-2 (red) antibodies on stage 17-38 embryos. Brightfield DIC 
images are shown in the left panel. Mono-colour images for RECK and TIMP-2 are 
presented individually. Colocalization of RECK and TIMP-2 (yellow) is shown on the 
right panel. Dotted line in stage 28 merged image indicates overlapping signal within the 
middle of somites. Dashed line in stages 34 and 38 merged images indicates overlapping 
signal along the ventral neural tube.  Scale bar= 100 µm. Abbreviations: E=endoderm, 
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural 
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT. 
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neural tube upon closure (Le Douarin and Kalcheim, 1999), it appears that RECK 
proteins are present within neural crest cells at this stage (Fig. 3.1B2 and Fig. 3.2B2). This 
is evident in Fig. 3.2B2 (arrow) where RECK staining appears to localize in cells that are 
located along the periphery of the neural tube, not within the neural tube itself, in 
agreement with the known migratory path of neural crest cells (Le Douarin and 
Kalcheim, 1999). Indeed, RECK is essential during neural crest cell migration in 
zebrafish (Prendergast et al., 2012), and I have previously shown RECK mRNA and 
protein staining within the head and branchial arches, structures in the embryo where 
neural crest cells are known to migrate (Lumsden et al., 1991; Tosney, 1982).  
There was also faint RECK staining in endodermal cells at stage 20 embryos 
(Fig. 3.1B2, 3.2B2). At stage 28, when axis elongation is prevalent and 
mesodermal/neural tissues are being patterned, RECK proteins were localized in the 
dorsal epidermis and within most areas of the neural tube (Fig. 3.1C2, 3.2C2), which is 
consistent with my past in situ data of RECK (Willson et al., 2015). RECK also localized 
to the middle portion of the somitic mesoderm. (Fig. 3.1C2, 3.2C2). This horizontal 
RECK expression domain in the middle of the somite lies across the differentiating 
dermatomes, myotomes, and sclerotomes, which are differentiating vertically. This 
suggests RECK is present briefly in the mid-region of the dermatomes, myotomes, and 
sclerotomes as they are being differentiated; in agreement with past studies that have 
shown RECK as a regulator of myogenesis in vitro (Echizenya et al., 2005).  
By late tailbud stages (stage 34), RECK staining was absent in the somites, but 
appeared in the cells surrounding the notochord (Fig. 3.1D2, 3.2D2). Also at stages 34 and 
38, RECK localization shifted from being present within the entire neural tube (stage 28), 
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to becoming more pronounced along the ventral side of the neural tube (stages 34) 
(Fig. 3.1C2-E2, 3.2C2-E2). RECK staining was also present in the anterior (head) region of 
stage 38 embryos in the epidermis and eye region, consistent with my past in situ data 
(Willson et al., 2015), and as with the mid AP-axis sections, along the ventral side of the 
neural tube (Fig. 3.4A2, B2). 
Given that RECK has been implicated to play a role in neurogenesis in mice 
(Muraguchi et al., 2007), it is consistent with my results that show RECK proteins 
localize to the epidermis and neural tube during X. laevis development. Neurulation 
involves ectodermal migration, patterning, and differentiation of neural tissue. This 
patterning, particularly the dorsoventral (D-V) patterning of the neural tube after closure, 
is well characterized and involves dorsal BMP signals and ventral Shh signals (De 
Robertis and Kuroda, 2008). Ventral Shh signals are responsible for motor neuron 
differentiation and dorsal BMP signals are responsible for sensory neurons, with 
interneurons present in between. The distinct shift in RECK localization from the dorsal 
(stage 20), to entire (stage 28), to ventral side (stage 34) of the neural tube implicates its 
role in D-V differentiation, though not of any specific neuron type. Here, I found that 
RECK proteins appear to be present when patterning and differentiation events are 
occurring. 
3.3.2 MT1-MMP Localization During Early X. laevis Development 
Following RECK protein localization, I next examined MT1-MMP localization. 
While MT1-MMP has been associated with events that encompasses extensive ECM 
degradation and remodeling, including important roles during frog metamorphosis 
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(Hasebe et al., 2007; Jung et al., 2002; Patterton et al., 1995), MT1-MMP protein 
localization within X. laevis neurulation has not been examined. 
During neurulation (stages 17 and 20), MT1-MMP protein staining displayed a 
strikingly similar localization pattern as RECK. At stage 17, prior to neural tube 
formation, there was punctate MT1-MMP staining that was not associated with distinct 
tissues (Fig. 3.1A3, 3.3A3). However, at stage 20 following neural tube closure, 
MT1-MMP proteins localized to the dorsal side of the neural tube and along the 
epidermal tissue (Fig. 3.1B3, 3.3B3). This staining pattern on the dorsal side of the neural 
tube appears to be localized where neural crest cells reside, similar to what I saw with 
RECK. This is not surprising, since recently MT1-MMP has been shown to be required 
for proper neural crest cell migration during X. laevis development (Garmon et al., 2018). 
At stage 28, MT1-MMP staining was distinct, localizing to the entire neural tube, 
somitic mesoderm, and epidermis (Fig. 3.1C3, 3.3C3). During the late tailbud stages 
(stages 34 and 38), MT1-MMP staining disappeared from the somites, became more 
robust along the epidermis, and shifted to the ventral side of the neural tube 
(Fig. 3.1D3-E3, 3.3D3-E3). MT1-MMP also exhibited staining in the anterior (head) 
region of stage 38 embryos in the epidermis, eye region, and, as with the mid AP-axis 
sections, along the ventral side of the neural tube (Fig. 3.4A3, C3). Like RECK, 
MT1-MMP was present transiently in the middle of somites at stage 28, with a distinct 
shift in MT1-MMP localization from the dorsal (stage 20), to entire (stage 28), to ventral 
side (stage 34) of the neural tube during the tailbud stages. These observations implicate 
a role for MT1-MMP in patterning and differentiation.  
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Figure 3.3. Localization of TIMP-2 and MT1-MMP proteins during early X. laevis 
development. 
IHC was performed using Alexa Fluor 555-labeled anti-TIMP-2 (red) and Alexa Fluor 
488-labeled anti MT1-MMP (green) antibodies on stage 17-34 embryos. Brightfield DIC 
images are shown in the left panel. Mono-colour images for TIMP-2 and MT1-MMP are 
presented individually. Colocalization of TIMP-2 and MT1-MMP (yellow) is shown on 
the right panel. Dotted line in stage 28 merged image indicates overlapping signal within 
the middle of somites. Dashed line in stage 34 merged image indicates overlapping signal 
along the ventral neural tube. Scale bar= 100 µm. Abbreviations: E=endoderm, 
Ep=epidermis, D=dorsal NT, DF=dorsal fin, N=notochord, NC=neural crest, NP=neural 
plate, NT=neural tube, S=somitic mesoderm, V=ventral NT. 
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Figure 3.4. Localization of RECK, MT1-MMP, and TIMP-2 proteins in the anterior 
region of stage 38 X. laevis embryos. 
IHC was performed using Alexa Fluor 555-labeled anti-RECK and anti TIMP-2 (red) and 
Alexa Fluor 488-labeled anti-MT1-MMP and anti-RECK (green) antibodies on stage 38 
embryos. Brightfield DIC images are shown in the left panel. Mono-colour images for 
RECK, MT1-MMP, and TIMP-2 are presented individually. Colocalization of RECK and 
MT1-MMP, RECK and TIMP-2, or TIMP-2 and MT1-MMP (yellow) is shown on the 
right panel. Scale bar= 100 μm. Abbreviations: E=endoderm, NT=Neural tube.  
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3.3.3 TIMP-2 Localization During Early X. laevis Development 
TIMP-2 not only inhibits MMPs but has also been associated with a number of 
cell signaling pathways due to its pericellular localization (Stetler-Stevenson 2008). I 
have previously shown that TIMP-2 overexpression in X. laevis embryos resulted in 
severe developmental defects and death (Nieuwesteeg et al., 2012). To further elucidate 
the role of TIMP-2 during development, I analyzed the spatial localization of TIMP-2 
proteins in X. laevis embryos. 
During neurulation (stages 17 and 20), while present in the ectoderm and dorsal 
side of the neural tube, TIMP-2 proteins were localized to a number of tissues including 
somitic mesoderm and endoderm (Fig. 3.2A3, B3 and 3.3A2, B2). As I saw with RECK 
and MT1-MMP, TIMP-2 staining also occurred along the dorsal side of the neural tube 
where the neural crest resides (Fig. 3.2A3, B3 and 3.3A2, B2), which coincides with past 
studies implicating a role for TIMP-2 in the migration of neural crest cells in chick 
(Cantemir et al., 2004).  
In the tailbud (stage 28), there was robust TIMP-2 staining in the entire neural tube, the 
middle of the somites, and epidermis (Fig. 3.2C3, 3.3C2), similar to RECK and 
MT1-MMP. By stage 34, TIMP-2 staining within the neural tube decreased and shifted 
ventrally, was greatly reduced in the somites, but persisted in the epidermis. Punctate 
TIMP-2 staining also appeared in some endodermal cells during these stages (Fig. 3.2D3, 
3.3D2). By stage 38, TIMP-2 again exhibited punctate staining within the entire neural 
tube, as well as the eye (Fig. 3.4B3, C2). Like RECK and MT1-MMP, TIMP-2 was 
present transiently in the middle of somites at stage 28, with a distinct shift in TIMP-2 
localization from the dorsal (stage 20), to entire (stage 28), to ventral (stage 34) side of 
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the neural tube during the tailbud stages, which also implicates a role for TIMP-2 in 
patterning and differentiation. 
3.3.4 RECK, MT1-MMP, and TIMP-2 Exhibit Similar Localization 
Patterns 
The relationship between MT1-MMP, RECK, and TIMP-2 has been examined in 
vitro, however, due to the complex nature of amniote vertebrate embryos and the 
redundant functions of MMPs and TIMPs, it has been difficult to elucidate any 
cooperative roles they may play in vivo. Here, the examination of anamniote frog 
embryos allows us to examine their localization in very early developmental processes. 
RECK, MT1-MMP, and TIMP-2 exhibited distinct overlapping expression 
patterns throughout all stages examined (summarized in Table 3.1). Shortly after neural 
tube closure (stage 20) and in early tailbud stages, RECK, MT1-MMP, and TIMP-2 
proteins were localized to the dorsal side of the neural tube and along the epidermal 
tissue (Fig. 3.1B4, 3.2B4, 3.3B4). The localized staining of all 3 proteins at the most dorsal 
spot of the neural tube and alongside the left and right periphery of the neural tube 
suggest they are present within the neural crest cell migration domains (Fig. 3.1B4, 3.2B4, 
3.3B4). Without the use of a neural crest cell marker, however, the migration of this 
transient population of cells could not be observed in later stages (stages 28-38). Since all 
3 proteins have been implicated individually to play an important role in the migration of 
neural crest cells (Cantemir et al., 2004; Garmon et al., 2018; Prendergast et al., 2012),  
future work examining if MT1-MMP, TIMP-2, and RECK interact with each other to 
properly regulate neural crest cell migration would be of great interest.   
 At stage 28, when somitogenesis (segmentation and differentiation) is ongoing, 
100 
 
Table 3.1: Summary of the spatial expression pattern of RECK, MT1-MMP, and 
TIMP-2 proteins in various tissue types throughout early X. laevis developmental 
stages.   
Tissue Type Neurula 
(Stages 18-20) 
Early Tailbud 
(Stage 28) 
Late Tailbud 
(Stages 34-38) 
Epidermis RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
Neural Tube RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
Somites TIMP-2 RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
Notochord ----- ----- ----- 
Endoderm RECK 
MT1-MMP 
TIMP-2 
----- RECK 
MT1-MMP 
TIMP-2 
Eye Region N/A RECK 
MT1-MMP 
TIMP-2 
RECK 
MT1-MMP 
TIMP-2 
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all 3 proteins localized to the middle of the somitic mesoderm (Fig. 3.1C4, 3.2C4, 3.3C4). 
By stages 34 and 38, when signals for myotome, dermatome, and sclerotome 
specification are largely complete, RECK, MT1-MMP, and TIMP-2 localization within 
the somites is reduced while at the same time their localization within the neural tube 
shifts to the ventral side (Fig. 3.1-3.3D4-E4). All 3 proteins also localize in endodermal 
tissues in the late tailbud stages (Fig. 3.1-3.3D4-E4). 
3.4 Conclusions 
Due to their highly similar localization patterns throughout X. laevis development, 
my results suggest that RECK, MT1-MMP, and TIMP-2 function together during 
different developmental events to influence cell behaviour and ECM remodeling. Despite 
the original description of MMPs as enzymes that remodel the ECM, and TIMPs and 
RECK as inhibitors of this process, the pericellular localization of MT1-MMP, RECK, 
and TIMP-2 suggests that they have regulatory activities independent of their ECM 
remodeling role. Indeed, similar to the expression analysis of Nuttall et al. (2004), where 
they suggest that MT-MMPs are expressed in cells that are in an active state and high 
expression of TIMPs are associated with the maintenance of tissue integrity, here, I see 
colocalization of MT1-MMP, TIMP-2, and RECK in later developmental stages in which 
tissues undergo patterning and differentiation (Table 3.1). While my findings do not 
preclude the modulation of ECM remodeling, my data do support an additional important 
role for these proteins in the patterning and differentiation of the neural tube and somites. 
Early embryogenesis requires the control of cell proliferation, cell migration, 
differentiation and ultimately distinct cell functions - processes that need to be 
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coordinated by molecules that govern such events - molecules such as RECK, 
MT1-MMP, and TIMP-2. 
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3.5 Supplementary Data 
Figure S3.1 Schematic diagram representing the location of the transverse sections 
on X. laevis embryos.   
Transverse sections (10 µm apart) were made in the mid anterior-posterior axis (as 
delineated by the boxes) of (a) neurulating embryos (stages 17 and 20) and (b) early/late 
tailbud embryos (stages 28, 34, and 38). (c) Transverse sections (10 µm apart) were made 
in the anterior head region (as delineated by the box) in late tailbud embryos (stage 38). 
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Figure S3.2 Validation of antibodies using Western blotting. 
(a) A blot probed with human rabbit anti-RECK shows a specific band at the expected 
molecular weight (110 kDa) in X. laevis A6 cell lysate. (b) A blot probed with human 
mouse anti-TIMP-2 shows a specific band at the expected molecular weight (21 kDa) in 
X. laevis A6 cell lysate. (c) A blot probed with human rabbit anti-MT1-MMP shows a 
specific band at the expected molecular weight (63 kDa) in X. laevis whole embryo 
lysate. 
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Figure S3.3 Validity of antibodies. 
IHC was performed using only secondary antibodies (Alexa Fluor 555-labeled 
anti-mouse (red) and Alexa Fluor 488 anti-rabbit (red)) and costained with DAPI (blue) 
on stage 34 embryos to establish specificity in the experiment (right panels). Sections 
were also probed with both primary RECK antibodies used in these experiments (Alexa 
Fluor 555-labeled mouse anti-RECK (red) and Alexa Fluor 488 labeled rabbit anti-RECK 
(green)) and costained with DAPI (blue) to validate their specificity. Colocalization is 
indicated on the bottom right panel (yellow). Brightfield DIC images are shown on the 
left panels. 
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Chapter 4  
4 Modulation of RECK Levels in Xenopus A6 Cells: Effects on 
MT1-MMP, MMP-2 and pERK Levels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is in press as “Willson, J.A., Bork. B., Muir, C.A., and Damjanovski, S. 
(2019). Modulation of RECK levels in Xenopus A6 cells: effects on MT1-MMP, MMP-
2, and pERK levels. Journal of Biological Research. DOI: 10.1186/s40709-19-0108-8.” 
The text has been modified from the original manuscript to adhere to formatting 
guidelines for this thesis. Experiments were designed and carried out by J.A.W. B.B. 
assisted with zymography and C.A.M. assisted with qPCR as part of their 4999E honours 
thesis projects. S.D. provided funding, resources, and intellectual contributions.   
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4.1 Introduction 
Remodeling of the ECM primarily occurs through the combined action of MMPs 
and their endogenous inhibitors, TIMPs, and RECK (Visse and Nagase, 2003). The 
RECK gene encodes a GPI-anchored protein with 3 protease inhibitor-like domains called 
Kazal motifs. RECK was initially classified as a tumour suppressor protein due to its 
ability to suppress metastasis when ectopically expressed in transformed cells (Takahashi 
et al., 1998). In vitro studies have shown that RECK can inhibit MMP-2 and MMP-9, 
secreted gelatinases associated with important developmental events and diseases, as well 
as MT1-MMP, a multi-functional cell surface MMP (Takagi et al., 2009; Takahashi et al., 
1998; Oh et al., 2001). Many studies have investigated the embryonic role of MMPs. 
Perhaps due to redundant functions between family members, mice knockouts of each 
MMP, apart from MT1-MMP, and all TIMPs are viable (Amar et al., 2017). This 
positions MT1-MMP as a uniquely important molecule, and therefore its regulation by 
other agents, such as RECK, is of interest. Likewise, studies have implicated the 
importance of RECK during development, as RECK knockout in mice is embryonic 
lethal. In both mice and fish, loss or knockdown of RECK causes defects in angiogenesis 
and neurogenesis, in part due to aberrant regulation of MMPs (Chandana et al., 2010; 
Muraguchi et al., 2007; Oh et al., 2001; Prendergast et al., 2012). In addition, RECK has 
been shown to play a role in cell migration signaling pathways independent of its 
MMP-inhibitory role (Walsh et al., 2015).  
Previous studies using epithelial breast cancer cells have revealed a complex 
pattern of expression between MT1-MMP levels and ERK activation into pERK, as well 
as pro-MMP-2 activation into MMP-2 (Cepeda et al., 2016; 2017; Willson et al., 2017). 
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MCF-7 cells stably expressing extremely high levels of MT1-MMP demonstrated low 
ERK activation and high pro-MMP-2 activation. Conversely, cells with low levels of 
MT1-MMP demonstrated high ERK activation and low pro-MMP-2 activation (Cepeda et 
al., 2016). Treatment with the broad spectrum MMP inhibitor Batimastat (BB94) 
increased MT1-MMP expression, but decreased MMP-2 activation and did not alter 
pERK protein levels (Cepeda et al., 2017). In MDA-MB-231 cells, inhibition of 
pro-MT1-MMP activation elevated global MT1-MMP and pERK levels, but decreased 
MMP-2 levels (Willson et al., 2017). These studies demonstrated that when MT-MMP 
levels are altered, pERK and MMP-2 activation levels alter in different ways depending 
on treatment. This suggests a mechanism that may involve more molecules than just 
MT1-MMP in the activation of ERK and pro-MMP-2, with RECK possibly playing an 
important role. I have cloned (Fig. 2.1) and characterized RECK expression during 
X. laevis development (Fig. 2.2), showing that RECK is present at stages where ECM 
remodeling events are associated with neural function. My recent in vivo examination of 
RECK, MT1-MMP, and TIMP-2 show that these proteins colocalize in the dorsal axis of 
X. laevis tailbud embryos, particularly in the neural tube (Fig. 3.1-3.4). Several other 
studies have also described interactions between RECK and MT1-MMP proteins in vivo 
and in vitro (Dong et al., 2010; Nambiar et al., 2016; Tang et al., 2018), with RECK 
being shown to complex with MT1-MMP at the cell surface to both attenuate its 
proteolytic activity and modulate its endocytosis from the cell surface (Miki et al., 2007).  
To corroborate past in vitro work that link MT1-MMP and pERK levels, as well 
as build on my X. laevis in vivo localization of MT1-MMP and RECK, in this chapter I 
used an in vitro examination of X. laevis A6 epithelial cells, one of the few in vitro cell 
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types available for X. laevis, to confirm the importance of RECK as it relates to 
MT1-MMP, pERK, and MMP-2 protein levels. I used a MO approach to knock down 
RECK levels, plasmid transfection to overexpress RECK, and PI-PLC treatment to cleave 
RECK proteins from the surface of A6 cells. RECK knockdown did not alter MT1-MMP 
protein levels, ERK activation, or MMP-2 activity levels. RECK overexpression and 
PI-PLC treatment both resulted in increased MT1-MMP protein levels and MMP-2 
activity levels. Only RECK overexpression decreased pERK protein levels in A6 cells. 
From these results, it is suggested that optimal levels of RECK present on the cell surface 
are important for modulating MT1-MMP protein levels and MMP-2 activation.  
4.2 Materials and Methods 
4.2.1 Morpholino Design 
The design and synthesis of MOs were carried out as described in Section 2.2.1. 
A translation-blocking RECK MO and β-catenin MO were engineered as described in 
Section 2.2.1. Standard scrambled MO (antisense: 3’-CCTCTTACCTCAGTTACAATTT 
ATA-5’) were also purchased from Gene Tools as an additional control. 
4.2.2 Cell Culture Conditions, Endo-Porter Treatments, Transfections, 
and PI-PLC treatments 
X. laevis A6 cells (ATCC®CCL-102TM) were maintained at 24°C in Leibovitz’s 
L-15 Medium (Wisent Inc.) containing 10% fetal bovine serum (FBS) and 1% penicillin 
(100 U/mL)/streptomycin (100 μg/mL) (Fox et al., 2014).  
For RECK knockdown, cells were seeded on 35 mm dishes at a density of 
1x106 cells. After 24 hours, spent culture medium was replaced with medium containing 
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Endo-Porter reagent and MO oligos (Gene Tools) according to manufacturer’s 
instructions. 48 hours following treatment, cell lysates were collected in RIPA buffer. 
MOs were used in dosages of 1, 10, or 20 μM. Following confirmation of RECK protein 
decrease, 20 μM MO treatment was used in subsequent experiments.  
For RECK overexpression, cells were seeded as above. 24 hours later, cells were 
transfected with hemagglutinin (HA)-tagged RECK in pcDNA3.1 using Lipofectamine 
2000 (Thermo Fisher) according to manufacturer’s instructions. Another 24 hours 
following transfection, cell lysates were collected using RIPA buffer. The generation of 
the full-length RECK cDNA construct is described in Section 2.2.2, with the HA tag 
being inserted just following the N-terminal signal sequence such that it would not be 
removed during secretion, nor would it interfere with GPI anchor formation at the 
C-terminal end.   
 PI-PLC is an enzyme from Bacillus cereus that cleaves GPI-linked proteins, such 
as RECK, from the plasma membrane. 24 hours following transfection, 
RECK-transfected and mock-transfected (Lipofectamine only) cells were treated with 
100 U/mL of PI-PLC (Thermo Fisher) in serum-free L-15 media according to 
manufacturer’s instructions. 24 hours following PI-PLC treatment, cell lysates were 
collected using RIPA buffer.  
4.2.3 Quantitative Real-Time PCR 
To investigate changes in transcript levels, real-time qPCR was performed. Cells 
were seeded and treated as described in Section 4.2.2. Following treatment, RNA was 
extracted from cells using an RNeasy Mini Kit (Qiagen) according to manufacturer’s 
instructions. cDNA was synthesized and qPCR was carried out as described in Section 
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2.2.8. For quantification, the target genes (MMP-2, MMP-9, MT1-MMP, and TIMP-2) 
were normalized to the internal standard of EF1α (Krieg et al., 1998). Primer sequences 
are described in Section 2.2.8. Fold change was calculated according to the ∆∆CT 
method (Livak and Schmittgen, 2001). 
4.2.4 Immunoblot analysis 
To investigate changes in RECK, MT1-MMP, and pERK protein levels, 
immunoblotting was performed. Cells were seeded and treated as described in Section 
4.2.2. Following treatment, cells were washed 2X with PBS (pH 7.2) and disrupted using 
modified RIPA buffer. Collected cell lysates were shaken on ice for 20 minutes and 
sonicated 3X for 10 seconds each. Protein level was quantified using a bicinchoninic acid 
(BCA) assay (Thermo Scientific). 10 µg of protein per sample was mixed with 4X 
loading dye and subjected to a 10% SDS polyacrylamide gel and transferred to a PVDF 
membrane as described in Section 2.2.7. Membranes were blocked and probed with 
primary antibody (RECK, 1:200, Cell Signaling Technology, #3433; HA, 1:500, Santa 
Cruz, #sc-7392; MT1-MMP, 1:200, Millipore, #AB6004; pERK, 1:16000, Cell Signaling 
Technology, #4370; total ERK1/2, 1:4000, Cell Signaling Technology, #4695; β-actin, 
1:1000, Santa Cruz, #sc-47778) followed by secondary antibody as described in Section 
2.2.7. Signal was detected and quantified as described in Section 2.2.7. ERK1/2 
activation is presented as a ratio between pERK and total ERK1/2 band intensities. 
4.2.5 Gelatin Zymography 
To measure the activity of secreted MMP-2 and MMP-9 proteins, gelatin 
zymography was performed. Cells were seeded and treated as described in 4.2.2. 
24 hours later, culture media was replaced with serum-free L-15 media. 24 hours 
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following serum-free treatment, serum-free media was collected and mixed with 2X 
SDS-loading dye in a 1:1 ratio, with only 5 μL of sample being loaded into the gel 
(Hawkes and Taniguchi, 2010). To aid in the identification of active versus inactive 
forms of a MMP, the broad spectrum MMP inhibitor BB94 (10μM) was added to 
duplicate samples. Media samples were run on an SDS-containing 15% polyacrylamide 
gel, co-polymerized with 1% gelatin, at 140 V for 6 hours. A Triton X-100 (2.5%) 
incubation was then used to renature MMP-2 and MMP-9 proteins. Gels were placed in 
developing buffer (pH 7.5, 50 mM Tris, 200 mM NaCl, 5 mM CaCl2, and 0.02% Brij-35) 
at 37°C with gentle shaking. After 48 hours, gels were stained with 0.5% Coomassie blue 
for 1 hour followed by de-staining (50% methanol) for 2 hours. Gels were visualized and 
band intensities representative of enzyme activity were quantified using Bio-Rad 
ChemiDoc Imaging system and Bio-Rad Image Lab software.  As protein used for 
zymography was isolated from the media, the use of an internal (loading) standard was 
not possible. Accordingly, the ratio of active over total (pro, intermediate, and active) 
forms was determined for MMP-2. These ratios (active MMP-2/total MMP-2) were then 
used to calculate the percentage change of MMP-2 activation levels between control and 
treated cells. 
4.2.6 Statistical Analysis  
Statistical analysis and graphing were performed using Microsoft Excel. Data is 
presented as mean ± SD, except for qPCR results in Fig. 4.7 which are ± SEM. One-way 
ANOVA followed by unpaired student’s T-tests were used and indicated respectively in 
each figure legend. The different levels of significance are denoted as follows: ns, 
p>0.05; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001.  
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4.3 Results 
4.3.1 RECK Knockdown in A6 Cells Did Not Alter MT1-MMP or 
pERK Protein Levels nor MMP-2 Activity Levels 
To confirm that the RECK MO treatment decreased RECK, protein level in 
X. laevis A6 cells was measured following treatment with different concentrations of 
RECK MO. Immunoblotting demonstrated that RECK protein is endogenously expressed 
in untreated A6 cells. A dose-dependent decrease in cellular RECK protein level was then 
seen following treatment of increasing concentrations of RECK MO. (Fig. 4.1a). The 
decrease in RECK was significant when immunological signals were quantified, with the 
20 µM treatment reducing RECK protein levels by approximately 60%. (Fig. 4.1b). 
Having confirmed the efficacy of the RECK MO, I examined the levels of MMPs and 
their activity levels in A6 cells following RECK knockdown. RECK knockdown did not 
alter MT1-MMP (Fig. 4.2a) nor pERK protein levels (Fig. 4.2b) as shown by immunoblot 
analysis. However, this 60% knockdown in RECK was large enough to cause a cellular 
effect, as there was a change in transcription levels (Fig. 4.3). 
Zymography was then used to quantify the active and inactive secreted forms of 
MMP-2 and MMP-9 after RECK knockdown. Bands of gelatin degradation representative 
of MMP activity of specific molecular mass on zymograms were quantified. The addition 
of the broad spectrum MMP inhibitor BB94 was used to confirm the identity of active 
MMP-2 versus pro-MMP-2 and intermediate MMP-2 forms (Appendix E).  The amount 
of the active form of MMP-2 was compared to the total amount of MMP-2 (pro-, 
intermediate, and active forms). The active/total MMP-2 ratio was set to 1 in control 
cells. The relative level of MMP-2 activity did not change (there was the same ratio 
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Figure 4.1. Treatment of A6 cells with RECK MO resulted in decreased RECK 
protein levels. 
Immunoblot analysis was used to confirm knockdown of RECK following treatment of 
A6 cells with RECK MO using Endo-porter delivery reagent. Protein was extracted from 
cells 48 hours following treatment with increasing concentrations of RECK MO. 
(a) Knockdown of RECK protein occurred in a dose-dependent manner. β-actin was used 
as a loading control. (b) Quantification of protein levels in (a) were graphed and data are 
based on 3 biological replicates (mean ± SD) and normalized to control (set to 100%). 
Data are analyzed via t-test; *, p≤0.05; ***, p≤0.001; ****, p≤0.0001. 
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Figure 4.2. RECK knockdown did not alter MT1-MMP or pERK protein levels or 
MMP-2 activity levels.  
(a) Densitometry quantification of MT1-MMP immunoblotted protein normalized to 
β-actin. MT1-MMP protein levels did not significantly change in RECK knockdown cells 
compared to control (set to 1). β-actin was used as a loading control. b) Densitometry 
quantification of pERK normalized to total ERK levels. pERK protein levels did not 
significantly change in RECK knockdown cells compared to control (set to 1). (c) Gelatin 
zymography was used to measure protein activity of secreted pro-, intermediate, and 
active MMP-2 following RECK knockdown in A6 cells. Data are presented as the ratio 
between active and total (pro-, intermediate, and active) MMP-2 levels between control 
and RECK knockdown cells. Active/total MMP-2 levels did not significantly change in 
the media of RECK knockdown cells compared to control (set to 1). Graphed data are 
based on 3 biological replicates (mean ± SD). Data are analyzed via t-test; ns, p>0.05. 
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Figure 4.3. Effect of RECK knockdown on MMP-2, -9, MT1-MMP, and TIMP-2 
mRNA levels.  
Following RECK knockdown in A6 cells, MMP-2, MMP-9, and MT1-MMP mRNA 
levels did not change significantly compared to control, however, TIMP-2 mRNA levels 
decreased significantly. Changes in gene expression were measured relative to EF1α and 
normalized to control cells (set to 1). Results are based on 3 biological replicates (mean 
± SEM; technical replicates, N=9). Data are analyzed via t-test; **, p≤0.01. 
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of active to total MMP-2) after RECK knockdown (Fig. 4.2c). MMP-9 activity could not 
be detected in the media (Appendix F) at the previously described molecular masses: 
84 kDa (Cepeda et al., 2016; Nieuwesteeg et al., 2014) or 73 kDa (Fujimoto et al., 2006). 
4.3.2 RECK Overexpression in A6 Cells Caused an Increase in 
MT1-MMP Protein Levels and Relative Active MMP-2 Levels, 
and a Decrease in pERK Protein Levels 
After observing no change in MT1-MMP, pERK, and MMP-2 activation 
following RECK knockdown, I proceeded with overexpression of RECK in A6 cells. 
Transfection of an HA-tagged RECK construct was confirmed, as the level of RECK 
protein in transfected cells significantly increased (Fig. 4.4). This increase in protein was 
detected and quantified using both a RECK and HA antibody (Fig. 4.4).  
As was done with the knockdown treatment, cellular proteins of interest were 
quantified following RECK overexpression. Although no change was observed following 
RECK knockdown, RECK overexpression resulted in a significant increase in the level of 
MT1-MMP protein (Fig. 4.5a) as well as a significant decrease in the level of pERK 
protein (Fig. 4.5b). Following RECK overexpression, zymography of secreted proteins 
revealed a significant increase in the relative level of active MMP-2 (Fig. 4.5c). Secreted 
MMP-9 proteins could not be detected via zymography.   
4.3.3 Treatment With PI-PLC Reduced Cell-Surface RECK Levels 
PI-PLC treatment (which releases GPI-linked proteins) was used to cleave RECK 
from the cell surface, and also allowed us to confirm the proper trafficking and 
localization of overexpressed RECK protein to the cell surface in the A6 cells.  As 
expected,   PI-PLC   treatment   significantly  reduced  the  level  of  membrane  localized 
129 
 
Figure 4.4. Transfection of full-length HA-tagged RECK constructs in A6 cells 
resulted in increased RECK levels.  
Immunoblot analysis was used to confirm overexpression of RECK protein following 
transfection with RECK cDNA constructs. Mock-transfected and GFP-transfected A6 
cells were used as controls. Protein was extracted from cells 24 hours following 
transfection. β-actin was used as a loading control. Top panel shows increased levels of 
RECK protein compared to control using a RECK antibody, while bottom panel confirms 
the presence of HA-tagged proteins only in RECK-transfected A6 cells using an HA 
antibody. Graphed data of top panel are based on 3 biological replicates (mean ± SD) and 
normalized to control (set to 100%). Data are analyzed via t-test; ***, p≤0.001.  
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Figure 4.5. RECK overexpression increased MT1-MMP protein and MMP-2 activity 
levels and decreased pERK protein levels. 
(a) Densitometry quantification of immunoblots of MT1-MMP protein normalized to 
β-actin. MT1-MMP protein levels significantly increased in RECK-overexpressing cells 
compared to control (mock-transfected cells) (set to 1). (b) Densitometry quantification 
of pERK normalized to total ERK levels. pERK protein levels significantly decreased in 
RECK-overexpressing cells compared to control (set to 1). (c) Gelatin zymography was 
used to measure protein levels of secreted pro-, intermediate, and active MMP-2 
following RECK overexpression in A6 cells. Data are presented as the ratio between 
active and total (pro-, intermediate, and active) MMP-2 levels between control and 
RECK-overexpressing cells. Active/total MMP-2 levels significantly increased in the 
media of RECK-overexpressing cells compared to control (set to 1). Graphed data are 
based on 3 biological replicates (mean ± SD). Data are analyzed via t-test; *, p≤0.05; **, 
p≤0.01. 
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RECK, both in control and RECK-overexpressing cells (Fig. 4.6).  
4.3.4 PI-PLC Treatment of A6 Cells Caused an Increase in MT1-MMP 
and Relative Active MMP-2 Levels 
To elucidate the role of RECK at the cell surface in modulating MT1-MMP, 
pERK, and MMP-2 activation, I shed GPI-anchored proteins, which includes RECK, 
from the surface using PI-PLC. PI-PLC treatment significantly increased MT1-MMP 
protein levels (Fig. 4.7a) but did not alter pERK levels (Fig. 4.7b). PI-PLC treatment 
caused an increase in the relative level of active MMP-2 (Fig. 4.7c). Secreted MMP-9 
protein could not be detected. Of note - PI-PLC treatment did not alter the transcription of 
a variety of genes (Fig. 4.8), nor did it alter the morphology, growth, or survival of these 
cells.  
4.3.5 Alteration in RECK Levels or PI-PLC Treatment had Varying 
Effects on MMP-2, MMP-9, MT1-MMP, and TIMP-2 mRNA 
Levels 
Having shown that altered RECK levels had varying effects on protein levels of 
MT1-MMP and pERK, I sought to better understand the mechanism of these changes by 
examining changes in mRNA levels. Following RECK knockdown, qPCR analysis did 
not reveal a significant change in the level of MMP-2, MMP-9, nor MT1-MMP mRNA. 
There was, however, a significant decrease in TIMP-2 mRNA levels (Fig. 4.3).  
Following RECK overexpression, PCR analysis revealed significant increases in 
MT1-MMP and MMP-9 transcript levels, but no changes in MMP-2 nor TIMP-2 
transcript levels (Fig. 4.8a). PI-PLC treatment of A6 cells did not alter the transcript 
levels of MMP-2, MMP-9, MT1-MMP, nor TIMP-2 (Fig. 4.8b).  
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Figure 4.6. Solubilization of RECK proteins following PI-PLC treatment.  
24 hours following transfection of RECK constructs, control and transfected A6 cells 
were treated with PI-PLC for 24 hours and cell lysates were collected and analyzed by 
Western blot. (b) Densitometry quantification confirmed that the level of RECK proteins 
bound to the cell was significantly reduced following PI-PLC treatment in both 
mock-transfected and RECK-transfected cells. β-actin was used as a loading control. 
Graphed data are based on 3 biological replicates (mean ± SD). Data are analyzed via 
t-test; *, p≤0.05; **, p≤0.01.    
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Figure 4.7 PI-PLC treatment caused an increase in MT1-MMP protein and MMP-2 
activity levels.  
(a) Densitometry quantification of MT1-MMP protein level normalized to β-actin in 
control A6 cells treated with PI-PLC. MT1-MMP protein levels significantly increased in 
PI-PLC-treated cells compared to untreated cells (set to 1). (b) Densitometry 
quantification of pERK normalized to total ERK levels. pERK protein levels did not 
significantly change following PI-PLC treatment. (c) Gelatin zymography was used to 
measure protein levels of secreted pro-, intermediate, and active MMP-2 following 
PI-PLC treatment in A6 cells. Data are presented as the ratio between active and total 
(pro-, intermediate, and active) MMP-2 levels between untreated cells and 
PI-PLC-treated cells. Active/total MMP-2 levels significantly increased in the media of 
PI-PLC-treated cells compared to untreated cells (set to 1). Graphed data are based on 3 
biological replicates (mean ± SD). Data are analyzed via t-test; ns, p>0.05; *, p≤0.05; **, 
p≤0.01. 
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Unlike MMP-2, MMP-9 transcript levels in A6 cells were extremely low (only 
being detectable after 32 PCR cycles). Although MMP-9 transcript levels altered under 
RECK manipulation (Fig. 4.8a), they never elevated enough to be detected using 
zymography even when transcript levels increased. 
4.4 Discussion 
Adult epithelial cells, unlike their embryonic counterparts, move and invade only under 
special situations, such as injury or disease. Past in vitro examination of MCF-7 epithelial 
breast cancer cells, which are poorly invasive, has suggested that MT1-MMP orchestrates 
this transition towards a more migratory phenotype (Cepeda et al., 2016; Walsh and 
Damjanovski, 2011; Walsh et al., 2015). While the roles of ECM remodeling proteins 
have gathered much interest due to their broad developmental and disease implications, it 
has become clear that there isn’t a defined relationship between the level of a MMP and 
the amount of ECM turnover (Cepeda et al., 2016). While not exhibiting overt abilities to 
remodel the ECM or to become mesenchymal, non-migrating epithelial cells express low 
levels of the enzymes and signaling molecules needed for these events. Indeed, A6 cells 
have basal levels of MT1-MMP, MMP-2, RECK and pERK proteins (Fig. 4.1, 4.2). It is 
this low and appropriately localized levels of MT1-MMP and TIMP-2 which can directly 
regulate enzymatic activity, including the activation of proMMP-2 (Cepeda et al., 2017; 
Itoh et al., 2001), as well as ERK cell signaling events (Cepeda et al., 2016; 2017) in 
human epithelial cells. To address if the maintenance of low levels of MMPs is a 
common mechanism seen in X. laevis epithelial cells, here I investigated the impact of 
altered RECK levels in the context of the ECM remodelers MT1-MMP and MMP-2, as 
well as pERK in X. laevis A6 cells. 
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Figure 4.8 Effect of RECK overexpression and PI-PLC treatment on MMP-2, 
MMP-9, MT1-MMP, and TIMP-2 mRNA levels.  
The levels of MMP-2, MMP-9, MT1-MMP, and TIMP-2 mRNA were measured 
following RECK overexpression and PI-PLC treatment in A6 cells using real-time qPCR. 
(a) Following RECK overexpression, MMP-2 and TIMP-2 mRNA levels did not change 
significantly, however, MMP-9 and MT1-MMP mRNA levels increased significantly 
compared to control. (b) Treatment of cells with PI-PLC did not change MMP-2, MMP-9, 
MT1-MMP, or TIMP-2 mRNA levels. Changes in gene expression were measured 
relative to EF1α and normalized to control cells (set to 1). Results are based on 3 
biological replicates (mean ± SEM; technical replicates, N=9). Data are analyzed via 
t-test; *, p≤0.05; **, p≤0.01.  
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The presence of MT1-MMP and active MMP-2 (measured by zymography) 
demonstrated that A6 cells have at the least a basal ability to remodel the ECM. When 
endogenous levels of RECK are reduced using MO treatment, no changes were seen in 
MT1-MMP and pERK protein levels, nor MMP-2 activation (Fig. 4.2). Despite its ability 
to act as an MMP inhibitor, reduced levels of RECK were not substantial enough to alter 
MT1-MMP or MMP-2 levels, nor the basal level of ECM remodeling that may be 
associated with them. However, this level of RECK knockdown was biologically relevant 
as it was enough to decrease TIMP-2 mRNA levels significantly (Fig. 4.3). Thus, it 
appears that A6 cells maintain low levels of RECK at the cell surface, levels which when 
further reduced, do not impact the protein levels of MT1-MMP, MMP-2, or pERK.   
As RECK knockdown did not alter MT1-MMP, pERK, nor MMP-2 activity 
levels, I next examined the effect of RECK overexpression in A6 cells. RECK impedes 
MT1-MMP activity by binding to its catalytic site and blocking its proteolysis, including 
its ability to activate pro-MMP-2 (Dong et al., 2010). However, RECK overexpression 
resulted in increased MT1-MMP mRNA and protein levels (Fig. 4.8a and 4.5a), and an 
associated increase in MMP-2 activation (Fig. 4.5c). While A6 cells did not lower their 
basal ECM remodeling abilities with respect to MT1-MMP and MMP-2 in response to 
lowered RECK levels, increased RECK did trigger A6 cells to alter MMP levels. This 
increase in MT1-MMP and MMP-2 levels could be a compensatory response with the 
cells increasing these MMP levels to maintain a basal ability to remodel the ECM in 
response to the increased levels of an inhibitor. Further, RECK is associated with 
increased MT1-MMP endocytosis (Miki et al., 2007). Accordingly, increased RECK 
levels may reduce cell-surface MT1-MMP protein levels, triggering the cells to increase 
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MT1-MMP production. This RECK-mediated increase in MT1-MMP endocytosis rates 
would also limit the ability of MT1-MMP to activate ERK, thus pERK levels would be 
reduced under RECK overexpression conditions. In the presence of increased levels of an 
MMP inhibitor, A6 cells attempt to maintain a basal level of ECM remodeling ability by 
increasing MMP levels.  
While A6 cells could tolerate the knockdown of RECK, as evident in their 
maintained MT1-MMP and MMP-2 levels, I next sought to examine the necessity for 
RECK to be membrane anchored. PI-PLC treatment was used to cleave RECK and other 
GPI-linked proteins from the cell surface. PI-PLC treatment of A6 cells did not alter 
transcript levels (Fig. 4.8b), nor did it alter the morphology, growth, or survival of these 
cells. By these measures, PI-PLC treatment of A6 cells was not detrimental, while 
immunoblot analysis did reveal a significant decrease in cell surface RECK levels 
(Fig. 4.6). 
Like RECK overexpression, PI-PLC treatment of A6 cells elevated both 
MT1-MMP protein and MMP-2 activation levels (Fig. 4.7a,c). A possible mechanism 
that may explain this is that while cell surface RECK may play a role in MT1-MMP 
endocytosis (Miki et al., 2007), solubilized forms of RECK cannot. Following PI-PLC 
treatment and RECK shedding, less MT1-MMP is internalized and recycled, with more 
remaining at the cell surface. This increased level of MT1-MMP can then also facilitate 
higher levels of MMP-2 activity. Indeed, the increase in MT1-MMP protein levels 
(Fig. 4.7a) despite unaltered MT1-MMP mRNA changes (Fig. 4.8b) can be explained by 
soluble RECK proteins not being able to recycle cell-surface MT1-MMP, independent of 
transcriptional changes.   
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Unlike RECK overexpression, which decreased pERK levels possibly due to 
increased MT1-MMP recycling, PI-PLC treatment, which potentially reduced 
MT1-MMP recycling, did not alter pERK protein levels in A6 cells (Fig. 4.7b). These 
results suggest that cell surface localization of RECK proteins are important in 
modulating MT1-MMP function.      
4.5 Conclusions 
X. laevis A6 cells express RECK, as well as pERK, MT1-MMP and MMP-2 
levels that facilitate ECM remodeling activity as seen by zymography. RECK knockdown 
did not alter MT1-MMP, pERK, nor MMP-2 activation and did not lower the ability of 
the cell to remodel the ECM. Unlike RECK knockdown, RECK changes (overexpression 
and cell surface shedding) that reduced the ability of the cell to remodel the ECM are 
compensated for by increases in MT1-MMP and MMP-2 levels as the cell tries to 
maintain a basal ability to remodel the ECM. A6 and other epithelial cells may attempt to 
maintain basal abilities to remodel the ECM even when challenged by changes in MMP 
inhibitor levels.  
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5.1 General Overview 
5.1.1 Context and Significance of this Research 
The ECM not only functions as a structural scaffold for tissues, but it also 
contributes to the regulation of cell fate and behaviour. For proper ECM remodeling, a 
delicate balance must exist between MMPs, which cleave components of the ECM, and 
their inhibitors, TIMPs and RECK. Disruption of this balance leads to aberrant ECM 
turnover, which is detrimental to the development and maintenance of multicellular 
organisms. TIMPs were originally thought to be the main inhibitors of MMPs, however, 
RECK also plays a crucial role in maintaining this delicate balance. RECK is a 
lipid-anchored protein whose function has been established as an inhibitor of cell 
migration in both development and disease models (reviewed in Willson et al., 2014). 
Not only are MMPs and their inhibitors important for tissue remodeling, but it has 
become increasingly evident that these proteins also play a critical role in cell fate by 
modulating cell signaling events (Cepeda et al., 2017; Chirco et al., 2006; 
Stetler-Stevenson, 2008; Walsh et al., 2015). Indeed, MMPs, TIMPs, and RECK are all 
expressed during differentiation events in addition to regions where ECM remodeling and 
large-scale cell movements are occurring (Nuttall et al., 2004). The interplay that exists 
between MMPs, TIMPs, and RECK is thus made even more complex because of their 
multifaceted roles. Although past studies have revealed an important role for RECK 
during embryogenesis (Oh et al., 2001; Prendergast et al., 2012; Yamamoto et al., 2012), 
the knowledge of the precise functions of RECK during this process is still limited. This 
research is the first comprehensive examination of RECK during X. laevis development.  
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5.1.2 Research Summary and General Conclusions 
The overall goal of this research was to investigate the role of X. laevis RECK 
during development and how it facilitates proper ECM remodeling and tissue patterning. 
I used a combination of in vivo and in vitro experiments to accomplish this goal. Data 
were organized into 3 chapters: Chapter 2: a) I analyzed the X. laevis RECK peptide 
sequence with a variety of vertebrate and invertebrate RECK sequences to determine 
evolutionary conservation of hallmark domains, and b) I knocked down RECK levels in 
X. laevis embryos and assayed for morphological changes in development as well as 
corresponding changes in developmental marker genes and ECM remodeling genes; 
Chapter 3: I examined the localization patterns of RECK, MT1-MMP, and TIMP-2 
proteins throughout early X. laevis development using IHC; Chapter 4: I used X. laevis 
A6 cells to investigate how RECK regulates MT1-MMP, MMP-2, and pERK levels.  
In general, I hypothesized that X. laevis RECK supports a role in regulating ECM 
remodeling, as inhibition of MMP activity is a main function of RECK. Indeed, I was 
able to demonstrate that RECK contributes to X. laevis development. Knockdown of 
RECK expression in embryos resulted in neural tube closure failure as well as axial and 
head defects (Fig. 2.5), suggesting uncontrolled ECM remodeling and impaired cell 
migration. These phenotypes were attributed to global changes in MT1-MMP, MMP-2, 
and TIMP-2 mRNA levels (Fig. 2.6). Moreover, I showed that X. laevis MT1-MMP and 
TIMP-2 colocalized spatially in the neural tube and different regions of the head where 
RECK was localized, particularly in the dorsal-ventral differentiation of the neural tube 
(Fig. 3.1-3.4). Finally, I revealed that RECK modulated MT1-MMP protein levels in 
X. laevis A6 cells, thereby affecting MMP-2 and ERK activation levels (Fig. 4.5, 4.7). 
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Overall, my findings support the model that RECK is a unique regulator of ECM 
remodeling and tissue patterning, whose absence leads to developmental defects due to 
deregulation of MT1-MMP and MMP-2.   
5.2 Contributions to the Current Knowledge of ECM Dynamics 
5.2.1 Characterization of X. laevis RECK 
 When I began this research, only the mature X. laevis RECK sequence, lacking the 
N- and C-terminal signaling domains, had been previously cloned by me. One of my first 
tasks was to finish cloning the full-length coding sequence of X. laevis RECK (Fig. 2.1) 
and perform a sequence analysis using a variety of vertebrate and invertebrate RECK 
sequences to determine evolutionary conservation (Table 2.1). The first part of Chapter 2 
revealed that all RECK sequences cloned to date, including X. laevis RECK, are highly 
conserved at the amino acid level and share all the domains characteristic of RECK, 
which was consistent with my original hypothesis.  
RECK proteins are rich in cysteine residues (9%) and contain 5 repeats of a 
putative cysteine knot motif located near their N-terminus (Table 2.1). The number and 
placement of these cysteines are highly conserved among both vertebrates and 
invertebrates. Based on a current NCBI Homologene search of RECK, there are 
9 vertebrates: 7 mammalian, as well as chicken and frog, that have been characterized to 
date. Among these 9 vertebrate RECK peptide sequences, there is 100% conservation of 
cysteines in each cysteine knot motif. Within the cysteine knot motifs are potential 
glycosylation sites at 5 asparagine residues that have been identified to contribute to 
RECK’s role as an MMP inhibitor (Simizu et al., 2005).  
Of the 3 Kazal motifs, which have been identified as MMP inhibitory domains 
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(Chang et al., 2008), only the 1st domain completely matches the defined consensus Kazal 
motif sequence (X8CX6CX7CX10CX2CX17C), whereas the other 2 domains only contain 
partial Kazal motif identities (Takahashi et al., 1998). The 1st Kazal motif shares 87% 
identity in mammals and shares 100% conservation of cysteines in vertebrates. Even the 
2 partial Kazal motifs are very well conserved and contain conserved cysteine residues as 
well as the same number of amino acids between the cysteine residues in vertebrates. The 
high conservation of these 2 partial Kazal motifs suggests that they may also contribute to 
protease inhibition. Indeed, evidence does show that these Kazal motifs play a role in 
MMP inhibition (Chang et al., 2008).    
The middle portion of RECK proteins also contains 2 partial EGF-like repeats. 
EGF domains are evolutionary conserved regions found in a variety of 
membrane-anchored and secreted proteins. Proteins that contain EGF-domains may have 
the potential to bind to EGF receptors and stimulate cell proliferation, survival, and 
differentiation (Wouters et al., 2005). The high conservation of these 2 domains among 
vertebrate RECK sequences suggests that these domains contribute to a cell signaling 
function that is independent of RECK’s MMP inhibitory role, as recent evidence has 
shown that RECK can trigger such pathways autonomously of MMPs (Walsh et al., 
2015). 
These characterized domains of RECK, although highly conserved, only make up 
a small portion of the RECK coding sequence. There are other highly conserved, but 
uncharacterized, regions within RECK that may also represent important functional 
domains. For example, during sequence analysis of RECK in Chapter 2, following the 
last cysteine knot motif, I identified a 32 amino acid region, which I termed LAD-RSC 
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(Fig. 2.1), that is the most conserved region of RECK (91% conserved in mammals and 
88% conserved in vertebrates) (Table 2.1). This sequence motif has not previously been 
reported nor does it have any known homology to other proteins, however, given its 
extremely high conservation, this suggests that the LAD-RSC domain may have global 
implications to RECK function. 
It is interesting to note that RECK sequences are almost 3,000 bp, and throughout 
evolution, there has never been a duplication or omission of any of the characterized 
domains, nor of the gene itself. Even in the X. laevis genome, which is allotetraploid, 
meaning that it may contain duplicates for some genes, I only found a single copy of the 
RECK gene. This was also seen in the zebrafish genome, which is also tetraploid. Kumari 
et al. (2018) only identified a single copy of the RECK gene. On the other hand, there are 
4 mammalian TIMPs that appear to be a result of gene duplication, since only 1 TIMP 
gene is found in insects, and not all orthologues are present in all vertebrates (Brew and 
Nagase, 2010). MMPs first appeared as basic proteins with a catalytic domain, but 
through gene duplication, fusion, and exon shuffling, acquired the additional domains and 
functional diversity currently exhibited by the various members of the MMP family 
(Fanjul-Fernández et al., 2010). But the RECK gene is the only one of its kind and shares 
high peptide sequence conservation among vertebrates. This strongly implicates that all 
vertebrate RECK proteins share a similar biological function.  
5.2.2 RECK is a Key Regulator During X. laevis Development 
It has been well-known for a long time that there needs to be a proper balance 
between MMPs and their inhibitors in order to facilitate controlled ECM remodeling 
during development. Numerous studies have already shown that disturbing this balance, 
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either by disrupting MMP or TIMP levels, results in a wide array of developmental 
defects (Lambert et al., 2004; Vu and Werb, 2000). However, unlike MMPs and TIMPs, 
in which the gene knockout embryos are still viable, most likely due to functional 
redundancy, there is only one RECK gene, and knockout of this gene in mice results in 
embryonic lethality (Oh et al., 2001). Therefore, RECK must play an essential role during 
development, although the exact mechanisms remain unclear. The second part of Chapter 
2 explored the consequences of knocking down RECK expression in X. laevis embryos. 
My data revealed for the first time that RECK contributes to tissue patterning during X. 
laevis development.  
RECK knockdown in 1-cell stage embryos led to severe developmental defects in 
neural tube closure, an event that relies on large-scale cell movements and extensive 
ECM remodeling. This was consistent with my original hypothesis, which stated that 
knockdown in RECK levels would cause neural tube defects in X. laevis embryos. 
Changes in chordin mRNA levels in RECK knockdown embryos coincided with this 
phenotype, as chordin plays an important role in inducing neural structures (Sasai et al., 
1994). When comparing data from Chapters 2 and 3, I observed that the sites of 
prominent defects in RECK knockdown embryos (the neural tube and head; Fig. 2.5) 
coincided with sites of abundant RECK expression in wildtype embryos (Fig. 3.1, 3.2). 
Also of note was the trending increase that occurred in the mRNA levels of FoxD3, a 
neural crest cell marker, in RECK knockdown embryos (Fig. 2.6). Indeed, in Chapters 2 
and 3, I revealed that RECK proteins are localized to regions where neural crest cells 
reside: on the dorsal side of the neural tube prior to migration (the neural crest) and in the 
branchial arches, a structure in the head region where neural crest cells eventually 
156 
 
migrate (Fig. 2.2, 3.1, 3.2). Given that past studies have already indicated an important 
role for RECK in the migration of neural crest cells (Prendergast et al., 2012), my results 
suggest that the axial and head defects that were seen in RECK knockdown embryos 
(Fig. 2.5) may have resulted from aberrant neural crest cell migration. In fact, the reduced 
head structures that were seen in RECK knockdown embryos is similar to the phenotypes 
observed in zebrafish when neural crest cell migration is disrupted (Tobin et al., 2008).    
Because RECK knockdown caused global changes in MT1-MMP and TIMP-2 
mRNA levels, along with RECK, I also investigated the spatial expression patterns of 
these 2 proteins during X. laevis development. The sites of RECK localization coincided 
with overlapping expression patterns of MT1-MMP and TIMP-2, especially in the D-V 
differentiation of the neural tube (as summarized in Fig. 5.1). This was consistent with 
my hypothesis, which stated that X. laevis RECK would colocalize with MT1-MMP in 
dorsal axial structures, including the neural tube and head region. Given that past in vitro 
studies have shown that RECK interacts with MT1-MMP on the cell surface (Oh et al., 
2001; Matsuzaki et al., 2018; Miki et al., 2007), it was not surprising that both proteins 
displayed highly similar expression patterns throughout early X. laevis development. 
What was intriguing, however, was that TIMP-2 also displayed a very similar expression 
pattern to RECK, although there is no evidence to suggest they interact with one another 
on the cell surface. But seeing as how MT1-MMP also shares the same expression pattern 
as TIMP-2, and there is evidence in vitro to show that TIMP-2 complexes with 
MT1-MMP (Itoh et al., 2001), it is more likely that TIMP-2 and RECK both interact with 
MT1-MMP and influence its behaviour during development, such as the ability of 
MT1-MMP to activate  MMP-2 (Itoh et al., 2001), or  the  ability of MT1-MMP to induce  
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Figure 5.1 Schematic representation of overlapping RECK, MT1-MMP, and 
TIMP-2 proteins in the D-V differentiation of the neural tube during X. laevis 
development. 
Schematic representation of transverse sections of stage 20, 28, and 34 X. laevis embryos. 
Red indicates overlapping expression patterns of RECK, MT1-MMP, and TIMP-2 
proteins in the D-V differentiation of the neural tube at stages 20, 28, and 34. 
Abbreviations: E=endoderm; Ep=epidermis; NT=neural tube; S=somites. 
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cell signaling cascades (ie. ERK signaling) (Cepeda et al., 2017; Takino et al., 2010).    
My global analysis in Chapter 2 showed that RECK knockdown altered 
MT1-MMP, MMP-2, and TIMP-2 mRNA levels (Fig. 2.6). Furthermore, in Chapter 3, I 
showed that RECK and MT1-MMP displayed highly similar expression patterns 
throughout early X. laevis development (Fig. 3.1-3.4), which is suggestive that they 
interact with one another during development. However, RECK’s interaction with 
molecules and specific cellular pathways are difficult to detect in multicellular embryos. 
Therefore, in Chapter 4, I analyzed the role of RECK on ECM dynamics in a 
well-established X. laevis cell line, kidney epithelial A6 cells. A6 cells act as typical 
epithelial cells and express many ECM regulatory genes, including RECK, MT1-MMP, 
MMP-2, and TIMP-2. MT1-MMP’s regulation of pro-MMP-2 and ERK activation 
position it as a key indicator of the cell’s ability to remodel the ECM and migrate. Thus, 
given that MT1-MMP and MMP-2 can be pivotal to ECM remodeling during 
development, I investigated how modulation of RECK levels would impact both of these 
MMPs in vitro.  
Although RECK knockdown did not alter MT1-MMP levels nor MMP-2 activity, 
RECK overexpression and PI-PLC treatment both increased ECM remodeling potential 
through increased MT1-MMP protein and relative MMP-2 activation levels. These 
results were contrary to my hypothesis, which stated that knockdown/shedding of RECK 
in X. laevis A6 cells would result in increased MT1-MMP and MMP-2 levels, whereas 
overexpression of RECK would result in reduced MT1-MMP and MMP-2 levels. Instead, 
I observed a compensatory feedback response, in which changes in RECK levels that 
reduced the ability of the cell to remodel the ECM (overexpression and cell surface 
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shedding) were compensated for by cellular increases in MT1-MMP levels and MMP-2 
levels as seen by zymography. Taken together, my results are highly suggestive that 
RECK is a key regulator of MT1-MMP in X. laevis (as summarized in Fig. 5.2).  
Although RECK is well established as a suppressor of cell migration due to its 
ability to inhibit MMPs, more recent studies have shed light on MMP-independent 
functions of RECK, particularly during cell fate and differentiation events. Most recently, 
Vallon et al. (2018) revealed that RECK is a receptor to the ligand Wnt7 in rat brain 
blood vessels and mediates canonical Wnt/ß-catenin signaling in endothelial cells by 
stabilizing active Wnt7 ligands. Interestingly, when I examined the localization pattern of 
RECK in Chapter 3, I saw that RECK, along with MT1-MMP and TIMP-2, localized in 
the D-V differentiation of the neural tube (Fig. 5.1). This patterning event relies on 
coordinated cell signaling events rather than ECM turnover events. Therefore, these 
results suggest a role for these proteins during patterning events that are independent 
from their roles as regulators of ECM remodeling. In fact, RECK has already been 
implicated to be an important player during neurogenesis in mice (Muraguchi et al., 
2007; Park et al., 2013).  
It is well known that a complex interplay exists between RECK, MMPs, and 
TIMPs, interactions that need to be examined to truly understand the role of RECK in 
ECM remodeling during development. Overall, my results support the view that MMP 
regulation is critical to ensure proper ECM remodeling during development. Furthermore, 
my results suggest that RECK is a key modulator of MT1-MMP in X. laevis.  
5.3 Limitations of this Research and Future Studies 
As  my research was  the  first  to  characterize  RECK  function  during  X. laevis 
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Figure 5.2 Model of RECK modulation of MT1-MMP in X. laevis.  
(a) Cell surface RECK interacts with MT1-MMP and promotes its internalization in 
X. laevis A6 cells. As a compensatory feedback response, A6 cells upregulate MT1-MMP 
expression to increase MT1-MMP protein levels on the cell surface. (b) Solubilized 
RECK (cleaved by PI-PLC) binds to and inhibits MT1-MMP activity but cannot promote 
MT1-MMP internalization. As a result, MT1-MMP protein levels (but not mRNA levels) 
increase in A6 cells.    
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development, I focused on global changes within the whole embryo. Consequently, I was 
only able to detect large-scale changes in ECM remodeling genes and developmental 
marker genes (Fig. 2.6) rather than tissue-specific changes. However, since proper ECM 
remodeling is critical for large-scale cell movements during development, it is quite 
likely that many tissues besides the neural tube were affected by RECK knockdown. 
Therefore, a more comprehensive analysis of the morphological defects that resulted 
from reduced RECK levels in X. laevis embryos is warranted. This should be 
accomplished through in situ analysis of developmental marker genes in RECK 
knockdown embryos versus wildtype. For example, analysis of crestin, a marker for 
migratory neural crest cells (Rubinstein et al., 2000), in RECK knockdown embryos 
would be of great interest given the fact that my results strongly suggest that neural crest 
cell migration was affected in these embryos. 
To attenuate the effects of RECK knockdown, future studies should co-inject 
MT1-MMP MOs in X. laevis embryos, as they are known to be inhibited by RECK. If the 
phenotype is rescued, this would imply that RECK is a key regulator of MT1-MMP in 
X. laevis. Finally, examination of changes in additional signaling markers, besides pERK, 
such as Notch, VEGF, or Wnt7a signaling, using Western blotting, may help link the 
non-MMP-inhibitory role of RECK.   
Although my IHC analysis confirmed that RECK colocalizes with MT1-MMP 
and TIMP-2 in the neural tube (Fig. 5.1), I did not investigate the specific cell surface 
binding partners of RECK during X. laevis development. However, my last chapter does 
suggest that RECK modulates MT1-MMP protein levels in X. laevis. To build on these 
results, immunocytochemistry experiments using fluorescently-labeled MT1-MMP 
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antibodies would be useful to confirm that RECK modulates MT1-MMP internalization 
in A6 cells.  Co-immunoprecipitation experiments could also be useful in determining 
potential cell surface binding partners for RECK in X. laevis A6 cells, such as Wnt7, 
EGF, and Notch ligands (Muraguchi et al., 2007; Vallon et al., 2018). RECK is a large 
protein with a number of highly conserved domains, the functions of most of which are 
currently unknown. Therefore, future work should involve site-specific mutations to 
disrupt the function of different domains, especially the highly conserved LAD-RSC 
domain, to determine if they contribute to the overall function of the protein, as was 
previously done with the glycosylation sites (Simizu et al., 2005). This may help further 
elucidate the potential non-MMP inhibitory roles of RECK.  
5.4 Conclusions 
ECM dynamics are very complex, in part due to differing ECM compositions as 
well as differing expression patterns of MMP and TIMPs/RECK in each tissue. RECK is 
a recently described player in mediating MMPs. Its large size and high evolutionary 
conservation suggest it plays an important role in vertebrates. This study is the first to 
characterize X. laevis RECK during early development. My results indicate that 
inappropriate expression of RECK interferes with embryogenesis and causes aberrant 
expression of MT1-MMP and MMP-2, both of which play a major role in cell migration. 
The colocalization patterns of RECK and MT1-MMP during neural tube differentiation 
in X. laevis as well as my demonstration in vitro that RECK modulates MT1-MMP and 
MMP-2 protein levels suggest that RECK and MT1-MMP function together during 
development to ensure proper ECM remodeling and cell signaling. Overall, this study not 
only supports the role for RECK as a modulator of ECM remodeling during development 
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but also sheds light on the importance of this protein during patterning and differentiation 
events. 
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Appendix B X. laevis RECK full-length coding sequence  
 
(Accession Number: KM225791.1) 
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Appendix C Amino acid sequences of the 3 Kazal motifs among different species  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. C.1. Clustal Omega alignment of the 3 Kazal motif domains of select animals.  
Amino acid sequences of the 3 Kazal motif domains among different species. Conserved 
cysteine residues are highlighted in red and conserved tyrosine residues are highlighted in 
blue.  
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Appendix D The developmental phenotypes of X. laevis embryos  
 
 
  
Number (%) of embryos at specified phenotype 1 day 
post fertilization 
Total 
number of 
embryos 
 
Normal Moderate Severe 
 
RECK 
MO 
0 83 (59%) 57 (41%) 140 
Control 138 (91%) 14 (9%) 0  152 
 
 
Fig. D.1. The developmental phenotypes of X. laevis embryos following RECK 
Morpholino injection into one-cell stage fertilized embryos. 
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Appendix E Zymography for BB94 treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. E.1. Zymography for BB94 treatment. 
Gelatin zymography was used to measure protein levels of secreted pro-, intermediate, 
and active MMP-2 following 10 µM BB94 treatment in A6 cells compared to untreated 
cells.  
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Appendix F Zymography for MMP-9 detection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. F.1. Zymography for MMP-9 detection. 
Gelatin zymography was used to measure the protein levels of MMP-2 and MMP-9 in A6 
cells. MMP-9 protein could not be detected in the media of A6 cells at the expected size 
of 84 kDa.  
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